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ABSTRACT
Natural products have provided considerable value for drug discovery over the past halfcentury. Nearly four fifth of drugs were natural products or inspired by natural compounds.
Bioactive secondary metabolites isolated from natural source, either fungal or terrestrial, are
relatively safer for human health and the environment and can serve as drug or as drug leads for
the development of synthetic or semi-synthetic analogs. Natural products have also been
successfully used in agriculture as plant growth regulators, signal transductions, fungicides,
herbicides and tranquilizers. In our continued efforts to identify bioactive compounds, seventyseven plant and fungal extracts were evaluated using a direct-bioautography assay coupled with
three Colletotrichum species to detect antifungal metabolites. Three crude extracts that showed
significant antifungal activity were selected for further bioassay-guided isolation. Various
chromatographic techniques including preparative thin layer chromatography, vacuum liquid
chromatography, flash chromatography, high pressure liquid chromatography and over pressure
layer chromatography were utilized to isolate biologically active secondary metabolites from
natural products of fungal and plant origin. Among all the techniques, over pressure layer
chromatography were first adopt here for preparative isolation of natural products. It turned out
to be a rapid and efficient method of exploiting co-migrating bioactive metabolites, and eleven
compounds including two new molecules were isolated by using this technique. The structure of
the isolated compounds was elucidated through various spectroscopic methods, including highresolution mass spectrometry, one and two-dimensional nuclear magnetic resonance
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spectroscopy. Finally, the isolated compound was submitted for several in vitro assays, including
antifungal, herbicidal, antibacterial, and cannabinoid and opioid receptor agonist assays. Some
compounds showed potent antifungal activity against strawberry pathogens and one compound
also showed good herbicidal and antibacterial activity. These compounds could be exploited as
drug leads to potential agrochemicals or pharmaceuticals. All the promising drug leads have been
submitted for antifungal testing using 24-well strawberry leaf disc assay.
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CHAPTER 1 BACKGROUND

1.1 NATURAL PRODUCT-BASED DRUGS OR DRUG LEADS
Natural products refer to small organic chemical molecules produced by plants, fungi,
bacteria and lower eukaryotes. They also include peptides, proteins, other larger-molecularweight toxin from marine sources, and hormones from animals (e.g. natural estrogens from
pregnant mare urine) 1. In terms of the availability of starting materials, plants and fungi provide
a rich source of numerous pharmaceutical and agrochemical agents. There are around 250, 000
types of plants in the world and it is reported that only 10% of them have been investigated.
Fungi are also good source of bioactive compounds and about 95% of fungal species have not
been studied 2, 3, 4. Plants and fungi therefore continue to be a great reservoir for identifying novel
bioactive secondary metabolites. Historically, the majority of new drugs were natural products or
were inspired by natural compounds 5, 6 and over 120 of the most important medicines, including
penicillin (1) and cyclosporine (2), are obtained from fungal extracts 4 (Figure 1.1).
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Figure 1.1 Some famous compounds derived from natural source.
Natural products can also serve as lead structures for the development of new synthetic or
semi-synthetic analogs. Many of the isolated lead natural compounds are available only in
extremely small quantities, especially those from marine organisms such as sponges. The
preparation of natural product analogs, which are not naturally occurring, may provide a good
yield of desired compounds. And it allows scientists to design and enhance the druglike
properties of the medicines that nature has provided, such as bioactivity, solubility and
pharmacokinetics. Of importance is that the analogs are easier to synthesize than the parent
compounds. Designing unnatural compounds that preserve or even improve biological activity,
while removing unnecessary molecular complexity, is the main aim of analog synthesis 7. Figure
1.2 shows two successful examples of natural product-inspired drug design by structural deletion
and unnecessary functionality removal from the parent natural products 8, 9.
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(4)

(3)

(5)

(6)

Figure 1.2 Two famous structural modification examples of natural product templates7.
E7389 (3), currently in phase I clinical trials, was generated from the total synthesis of
halichondrin B (4, HB), a highly cytotoxic marine natural product

8, 10, 11

. Zheng, et al.

discovered that the deletion of a large region of the molecule did not affect its antimitotic
properties

12

. Furthermore, replacing the easily cleaved lactone with a ketone maintained an in

vitro profile very similar to the parent compound but increased the stability in vivo13. Another
powerful illustration of structure simplification is the development of bryostain analog A.
Bryostatin 1 (5) is a very promising marine natural product and displays potent biological
activity against a variety of human diseases

14

. It is currently in phase II clinical trials as an

anticancer agent. Simplification of the scaffold region of Bryostatin 1 resulted in analog A (6),
which was more potent than the parent compound 15.

Despite these statistics natural products research has experienced a slow decline during the
past two decades 15. The main reason lies in the rapid development of combinational chemistry
and high-throughput screening (HTS) in pharmaceutical company 7. However, untapped
biological resources, “smart screening” methods
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, robotic separation with structural analysis,

metabolic engineering, and synthetic biology have prompted a renewed interest in natural
products as a source of chemical diversity and lead compound generation. Advance technologies
may provide a vast resource for the future discovery of pharmaceutical and agrochemical agents.

1.2 NATURAL PRODUCT-BASED FUNGICIDES
Natural products have also been successfully used in agriculture as fungicides, herbicides,
insecticids, algeacides, plant growth regulators, signal transductions, herbicides and tranquilizers
17

. Griseofulvin (7) (Figure 1.1) was the first reported agrochemical fungicide, which is still used

today in the treatment of fungal infections 18. After that, several other plant or bacterial natural
products were available on the market as plant protectants through the induction of systemic
acquired resistance (SAR) process including Messenger® (EDEN Biosciences, Inc., Bothell, WA)
and Serenade® (AgraQuest, Davis, CA), Sonata® (AgraQuest, Davis, CA), and Milsana® (KHH
BioSci, Inc., Raleigh, NC). Messenger is derived from a natural protein (harpin), which
stimulates a plant’s defense and growth mechanism to protect itself from adverse bacterial and
fungal diseases. Serenade and Sonata are both microbial-protectants with ability against Botrytis,
mildews, ruts, blight, and bacterial spot. Milsana is a plant extract widely used for preventive
control of powdery mildew. Of special importance, these naturally occurring plant protectants
are relatively safer and do not adversely affect the environment and invertebrates due to target
specific and biodegradability.

Why do natural products possess such particular specificity and potency compared to
artificially synthesized molecules? The answer lies in over millions of years’ evolutionary
selection by nature. Nature has its own high-through screening process for the optimization of
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biologically active compounds. Natural products are endowed with well-defined threedimensional structures carrying a number of functional groups (hydrogen bond acceptor/donors,
etc.) that synthetic molecules may lack 19. Additionally, the structures of the biological receptors
of such natural products (e.g. protein binding sites) normally have high conservations among
proteins of markedly different genetic sequences, such as secondary metabolites that have
evolved for a certain purpose by a producing organism may provide different but equally potent
effects in other organisms 15.

The common property in both agrochemical and pharmaceutical pursuits is chemistry.
Whether the bioactivity of a natural product is for an agrochemical or pharmaceutical application
depends on dose. Scientists found that there may be indistinguishable between therapeutic and
toxic properties of a compound except by dose. Because of numbers of natural products that have
been identified, it was unavoidable that agrochemical and pharmaceutical areas would eventually
meld.

1.3 OPIOID AND CANNABINOID RECEPTORS IN DRUG DISCOVERY
Opioid receptors belong to a large family of G protein-coupled receptors. Opioid-binding
sites were first discovered in 1973

20

. Since then, extensive pharmacological studies have been

done on a variety of opioid receptor types. To date, three opioid receptors have been identified
including µ, κ, and δ. Their activation can be induced by both endogenous opioid peptides and
exogenous opioid drugs, such as morphine21, which is capable of causing analgesia, respiratory
depression, euphoria, feeding, the release of hormones, inhibition of gastrointestinal transit, and
decreased bowel motility22, 23. Currently, the most clinically available opioid analgesics are µ-
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agonists that refer to morphine and its analogs. However, their use was restricted because of the
side effects including tolerance and physical dependency.

Cannabinoid receptors are also members of a large superfamily of G protein-coupled
receptors (GPCRs). There are two subunits of cannabinoid receptors including CB1 and CB2.
Previous studies showed that activation of cannabinoid receptors resulted in the stimulation of
appetite 24. Particularly, CB1 agonists were reported to regulate energy input and output through
shared central and peripheral mechanisms and CB1 antagonists was expected to contribute longperiod efficacy for weight loss 22.

Over the past thirty years, scientists have recognized that development of opioid and
cannabinoid receptors targeting drugs is efficient to cure or alleviate CNS symptoms. Although
many works have been done in the discovery and development of opioid and cannabinoid-based
therapeutics, there are few drugs acting on these two types of receptors. Dronabinol (8) is the
only drug acting on cannabinoid receptors in the clinic. However, this drug causes many side
effects such as confusion, headache, nausea, vomiting and among others

22

. It is apparent that

new molecules are needed to continue the fight. Natural products provide a major source of new
chemical scaffolds which act on opioid or cannabinoid receptors because small molecules with
novel structures and potency can be the biological probes to uncover what is behind these two
receptors and the mystery of many related CNS diseases, and also can be the leads for new
therapeutics.
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1.4 CURRENT SITUATIONS OF COMMERCIAL FUNGICIDES
Strawberry anthracnose is a serious disease in many areas of the world and particularly
severe in the southeastern United States where diseases are often enhanced by warm temperature
and frequent rains during the harvest season. Anthracnose is a disease that appears as black,
sunken lesions on leaves, stems, or fruits and is caused by fungi capable to produce their asexual
spores

25

. Strawberry anthracnose disease is mainly caused by filamentous fungi in the genus

Colletotrichum that often cause typical symptoms of anthracnose diseases on a variety of plants
including cereals, grasses, cucurbits, tomatoes, and are serious problems for strawberry (Fragaria
× ananassa Duch.) fruits and plant production worldwide 26. Colletotrichum species are defined
as destructive pathogens that cause significant economic damage to crops worldwide. The three
most common Colletotrichum species including Colletotrichum fragariae A. N. Brooks,
Colletotrichum acutatum J. H. Simmonds, and Colletotrichum gloeosporoides (Penz.)
Penz.&Sacc. can occur singly or in combination 27, 28.C. acutatum has a very wide host range and
can infect almond, apple, blueberry, and strawberry

29, 30, 31

. Strawberry anthracnose can be

devastating since other plant parts may be infected in addition to the fruit. This causes millions
of dollars in crop loss each year 32.

Phomopsis viticola Sacc. is another common plant pathogen that causes severe diseases of
grapes all over the world, known as Phomopsis cane and leaf spot disease. P. viticola (Ellis and
Everh.) B. sutton can infect canes, leaves, rachis and berries. It was reported that cane infections
acted as the primary source of inoculum, while rachis and berry infections caused the highest rate
reductions and economic loss 33. Another important species of Phomopsis, P. obscurans, causes
a disease known as leaf blight of the cultivated strawberry that became a serious problem in 1985.
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P. obscurans can infect foliage, runners, petioles, and fruits with a dark brown center surrounded
by light-brown rings with purplish halos 34, 35.

Botrytis cinerea Pers.: Fr. is a ubiquitous fungus that infects a wide range of important plants
and vegetables, including ornamentals, bulbs, and fruit crops in temperate regions. The pathogen
produced profuse conidia and mycelia on the surface of dead and infected stems and calyxes, and
cause Botrytis bunch rot of grapes and strawberries

36, 37, 38

. Fusarium oxysporum Schlechtend:

Fr causes a disease known as Fusarium wilt, which is a major problem in most cotton growing
regions of the world. In 1995, it causes huge economic loss in the cotton belt of the United States
39

.

Increasing incidence of fungal strain resistance and potential environmental and mammalian
toxicities, caused by application of conventional fungicides, are two factors that drive a need to
search for new plant protectants

40

. Particularly desirable is exploiting active natural products

with new chemical classes that might function by different modes of action than existing
fungicides, thus avoiding problems of cross-resistance to current chemicals. Bioactive natural
products isolated from plants or terrestrial fungi are safer for human health and the environment
and can be used in modern crop protection or serve as lead structures for the development of
synthetic or semi-synthetic analogs.

1.5 PRIMARY GOAL OF THIS STUDY
The primary goal of this study was to identify the secondary metabolites responsible for
the antifungal activity against plant pathogens from terrestrial and fungal organisms. Some
fractions or pure compounds also were tested for their opioid and/or cannabinoid receptor
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binding affinity, antibacterial and herbicidal activity. Plant and fungal crude extracts were
selected based on the antifungal bioautographic results. 59 plant and fungal extracts were
screened using a direct-bioautography assay to detect antifungal metabolites against three
Colletotrichum species and three of them, Diospyros virginiana, Cladosporium cladosporioides,
and Milogrante (Highlighted in yellow) showed promising antifungal activity and were selected
for further isolation study (Table 1.1).

Table 1.1 59 Extracts Screened For Antifungal Activity Using Direct-Bioautography.
Material
Anadenanthera spp.

Number
2762:6-10-2005

Part
Seeds (yopo)

Code
A-1

Weight (mg)
5.9

Berchemia scandens

BUR240394-8

Stem

B-1

5.2

BUR280394-2
IBEET7618
CON021100-4-A
MOBOT145
CON240700-3-A
CON310700-2-A
CON310700-2-B
CON310700-2-C
CON310700-2-D
CON310700-2-E
MOBOT165
MOBOT166
MOBOT26
MOBOT328
MOBOT329
MH/But
MH/HAH/EtOAc
MOBOT1014
--MOBOT1016

Root
Shoot
Leaf
PX
Stem &Root
Root
Bark
Xylem
Leaf
Fruit
LF
ST
ST
Fruit
LF-ST

B-2
B-3
B-4
C-1
C-2
D-1
D-2
D-3
D-4
D-5
D-6
D-7
D-8
D-9
D-10
E-1
E-2
H-1
H-2
H-3
H-4
H-5
I-1
I-2

5.2
5.4
5.9
5.4
5.4
5.4
5.4
4.9
5.6
5.7
5.7
5.5
4.9
6.6
5.5
4.8
5.2
5.3
5.4
5.3
4.6
6.1
6.3
5.1

L-1

5.2

Croton capitatus
Diospyros virginiana

Eupenicillium parvum
Hypericum hypericoides
H. hypericoides
Hypericum punctatum
Hypericum stans
HGC-1
Ipomoea purpurea
Ipomoea violaceae
Lactuca/Launae
taraxacifolia

	
  

CON200900-3-A
2744:4-16-2005
2761-6-7-05

PL
PL
PL
PL
Fungus
Whole Plant
Stem

9

Lagochilus inebrians
Leonotis leonurus
Leonurus cardiaca
Nelumbo nucifera
N. nucifera
N-2574US
Solanum carolinense
S. carolinense
Virola surianmensis
Virola theiodora
NZ-658
NZ-617
ATCC-5907
NZ-647
NZ-656
ATCC-38849
NZ-654
UK-168
NRRL-5507
NZ-574
NZ-648
C. echinulata
ATCC-48726
NRRL-13489
UK-115
Milogrante
NZ-652
NZ-610

2739:4-12-2005
2727
2766
2451
2453

Flower
Fungus
Whole Plant
Whole Plant

CON200900-2-A
3808:7-15-2008
2752:4-19-2005
2738:4-12-2005

Fungus

ATCC-60782
NRLA-17159
ATCC-42761

Fungus
Fungus
Fungus

extracts,

fractions,

4.7
5.0
4.4
5.3
4.8
5.2
4.9
5.9
5.2
5.2

Fungus
Fungus
Fungus
Fungus
Fungus
Fungus
Fungus
Fungus
Fungus
Fungus
Fungus
Fungus
Fungus
Fungus
Fungus
Fungus
Fungus
Fungus

ATCC-34655

Crude

L-2
L-3
L-4
N-1
N-2
N-3
S-1
S-2
V-1
V-2

sub-fractions

and

pure

compounds

of

Cladosporium

cladosporioides and Milogrante were also tested for opioid and cannabinoid receptor binding
affinity. Radio-ligand binding assays for opioid (subtype δ, κ and µ) and cannabinoid receptors
(CB1 and CB2) have been a useful tool in the discovery of novel agents. Active compounds were
isolated by bioassay-guided fractionation methods. The structures of purified compounds were
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elucidated using various NMR spectroscopy and mass spectrometry techniques. Absolute
configuration of chiral centers in compounds was assigned and confirmed by X-ray
crystallography, and/or chemical derivation. Pure compounds were further tested by 96microtiter diluted broth assay and 24-well plate strawberry leaf disc assay to determine their in
vitro potency against plant pathogens.
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CHAPTER 2 ANTIFUNGAL METABOLITES FROM THE ROOTS OF DIOSPYROS
VIRGINIANA BY OVERPRESSURE LAYER CHROMATOGRAPHY

2.1 INTRODUCTION

2.1.1 Pharmacology and Chemistry of Diospyros Species (American Persimmon)
Discovery of new crop protectants from natural products has received considerable interest as
alternatives to synthetic agrochemicals for use as pest and disease-control agents. This interest
stems from the fact that these are generally safer for human health and the environment.
Biologically active natural products can be used in modern crop protection or can serve as lead
structures for the development of new semi-synthetic analogs. Our current research efforts are
directed to the identification of natural product-based fungicides. Secondary metabolites may be
ideal candidates as plant protectants, since their mode of action is selected by nature’s evolution
that is likely to be different from existing agents, thus avoiding the problem of resistance of the
fungi to current fungicides.

Diospyros belongs to the family Ebenaceae which consists of three genera and ca. 500
species of trees and shrubs

41

, of which more than 350 species are distributed in tropical and

subtropical regions worldwide

42, 43

. Diospyros is the largest and the most economically

important genus of Ebenaceae. Most of them have a good yield of edible fruits, ebony and
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valuable timbers. D. kaki is the most well known species, which was originated in East China
and has been cultivated in Japan for centuries 44. The mixture of the leaf extract of D. kaki and
jasmine has been the major constituent of anti-tobacco smoking candies in Japan. Many other
Diospyros species have been reported to have important biological and pharmacological
activities. For example, D. peregrina and D. melanoxylon, have been used in folk medicine for
the treatment of inflammation and urinary discharges, and for enrichment of blood since olden
times 45. Plumbagin, the major component of D. kaki 46 is the first bioactive compounds isolated
from Diospyros species
activities

48

47

. It was reported to show mosquito antifeedant and insecticidal

. Various extracts of Diospyros species have also been used as medicines in ancient

Thailand, Japan, India and China 45. Famous examples include the uses of alcohol extracts of D.
usambarensis

49

and D. zombensis

50

as fungicidal and molluscicidal agents, and the uses the

leaves of D. diepenhorstii as piscicidal and molluscicidal agents

45

. The fruits of D. lotus have

been used as a sedative, antitussive, antiseptic, antidiabetic, antitumor, astringent, laxative,
nutritive and as a febrifuge 51.

In the past century, more than 130 Diospyros species have been phytochemically screened
and interestingly almost all parts (leaves, bark, roots, fruits) of the Diospyros species have been
detected for chemical constituents and biological evaluation. The most widely distributed
component is triterpenes, which was found in above 90% of Diospyros plants

45

. All the

triterpenes have a pentacyclic core in common and belong to lupane, ursane and oleananes
skeletons. The major compounds of lupane class, which have been reported from more than 25
plants, include lupeol, betulin and betulinic acid, with betulinic acid being the first lupane
derivative isolated from one Diospyros species52.
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Lupeol (lup-20 (29)-en-3β-ol) is a triterpenoid purified from many popular medical plants
such as Diplotropis ferruginea Benth
ozua

55

53

, Syzygium formosanum Hay

54

, Pimenta racemosa var.

, Tamarindus indica, American ginseng, and Crataeva nurvala, as well as a variety of

fruits and vegetables including olive, fig, mango, strawberry, white cabbage, green pepper

56

.

Previous studies found that lupeol is a multi-target agent with a broad range of biological
activities against inflammation, cancer, arthritis, protozoal, diabetes, heart diseases, renal toxicity
and hepatic activity

57

. The major significance of lupeol is that it causes no toxicity to normal

cells when administered in even higher doses58, which illustrates the fact that secondary
metabolites extensively present in edible fruits and vegetables, are potentially more safe than
synthetic molecules for human use.

The inhibitory effects on inflammation of lupeol have been widely studied under in vitro and
animal models. Nguemfo et al. stated that lupeol showed higher maximum inhibition in an
animal model than a well-known phytochemical α-Mangosteen at similar dose (57.14% vs.
38.70%) 59. Geetha et al. reported the use of lupeol in a mice model of arthritis to suppress the
phagocytic activity of macrophages, and T-lymphoeytes and CD4+ cell medicated cytokine
generation

60

. Furthermore, a recent study conducted by Vasconcelos and coworkers (2008)

showed that application of lupeol caused a significant reduction in eosinophils infiltration and in
Th2-associated cytokines (IL-4, IL-5, IL-13) levels responsible for the immune response in
asthma 53. Ding and coworkers concluded that lupeol reduced the LPS-induced IL-6 secretion at
concentration of l µM

60

. The mechanism of anti-inflammatory activity of lupeol has been

studied by several groups. Lupeol has the ability to decrease the generation of pro-inflammatory
cytokines such as tumor necrosis factor α (TNFα) and Interleukin β (ILβ) 61. Further studies
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showed that lupeol treatment can decrease the levels of type II cytokines IL-4, IL-5, and IL-13 in
a bronchial asthma mouse model 59.

Lupeol and its derivatives have also been studied for their great potential as anticancer agents
in several cancer cell lines including prostate, skin, pancreatic and breast cancer 56, 62, 63, 64, 65. It is
noteworthy that lupeol has been shown to exhibit strong antineoplastic and anti-proliferative
activity under in vitro and in vivo situations by directly inhibiting tumor growth, cell cycle
progression and inducing the apoptosis of tumor cells

66, 67, 68

. Lupeol was also reported to have

anti-mutagenic activity and can inhibit chemically induced DNA damage

69, 70, 71

. Recent studies

by Prasad and Nigam et al. showed that topical treatment of lupeol could prevent 7,12dimethylbenz [α] anthracene [DMBA]-induced DNA strand break in murine skin70 and
Benzo[α]pyrene[B(α)P]-induced genotoxicity in a mouse model

72

. Lupeol also has great

potential to modulate signaling pathways such as nuclear factor kappa B (NFκB) and the
phosphatidylinositol 3-kinase [PI3K]/Akt 73. Taken together, these compelling evidences warrant
that lupeol is a really attractive molecule that can be a lead scaffold for synthetic chemistry and
we need to pay great attention to it in further drug investigation.

Betulinic acid (3β-hydroxy-lup-20(29)-en-28-oic acid) is a common compound widely
distributed in many plant species with a number of pharmacological activities including antiinflammatory, anticancer, antimalarial, antibacterial, anthelmintic, antioxidant properties and
inhibition of human immunodeficiency virus (HIV)74. The sources of betulinic acid include
Betula alba (Betulaceae), Ziziphusspp. (Rhamnaceae), Syzygiumspp. (Myrtaceae), and
Paeoniaspp. (Paeoniaceae)74,
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. Hundreds of publications have described the application of

15

betulinic acid for treatment of cancer 76, 77, 78, viral infections 79, hair loss 80, and other conditions.
However, the most regarded activities of betulinic acid are anti-HIV-1 activity and specific
cytotoxicity against a variety of tumor cell lines 77.

In 1994, Fujioka et al. reported that betulinic acid was capable of inhibiting HIV-1
replication with an IC50 value of 1.4 µM 81. In light of its promising anti-HIV activity, a variety
of betulinic acid analogs were subsequently synthesized to enhance the anti-HIV activity.
RPR103611 was concluded to be the only low-molecular-weight analog to date that effectively
inhibits HIV infection at an envelope-dependent post-binding step with an IC50 value ranging
between 40 and 100 nM in various in vitro cell-based assays 82. SAR studies showed that the Aring of betulinic acid was not an ideal site for structure modifications 83. The mechanism of antiHIV of betulinic acid and betulin analogs appeared to be associated with viral entry and
maturation 75.

A report in 1995 showed that betulinic acid selectively inhibited human melanoma cells
grown in vitro

84

. The mechanism of anti-tumor activity of betulinic acid was thought to be

through induction of apoptosis independent of the cell’s p53 regulation 85. Betulinic acid and its
derivatives were found to have a high protein tyrosine phosphatase 1B (PTP1B) and
diacylglycerol acyltransferase (DGAT) inhibitory activity

86, 87

. Betulinic acid was reported to

show activity against TPA-induced tumors, ovarian, melanoma xenographs in mice models

88

.

Because of its selective cytotoxicity against tumor cells and lacking of side effects to normal
cells, betulinic acid became a very promising novel chemotherapeutic agent for the treatment of
HIV infection and cancer.
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Ursane is another class of pentacyclic triterpene that are widespread in the Diospyros species.
One representative metabolite in this class is ursolic acid (3-β-hydroxy-urs-12-en-28-oic acid),
which was isolated in good quantities from many Diospyros plants and other tea trees, spice
plants such as paulownia

89

. Ursolic acid has been reported to decrease incidence of gastric

ulceration induced by pyloric ligation 90, and also inhibit proliferation of multiple myeloma cells
91

.

Besides triterpenoids, the uniqueness of Diospyros genus is the presence of a large number of
napththoquinone metabolites, which all have a juglone framework. 7-methyljuglone (5-hydroxy7-methyl-1, 4-naphthoquinone) is a chief component in this class, and was previously isolated
and identified as an active component from the root extracts of Euclea natalensis with
titubercular and termiticidal activity 92. One recent report showed that 7-methyljuglone exhibited
intracellular and extracellular inhibition of M. tuberculosis comparable to streptomycin and
ethambutol 93. Because of its fairly simple chemical structure and pharmacological effects, many
scientists have paid attention to the total synthesis of this compound. It was first synthesized by
Cooke et al. in 1952 and improved by Musgrave et al. in 2001 94.

Shinanolone

(6-methyl-4,

8-dihydroxy-3,

4-dihydronaphthalene)

is

also

a

1,4-

naphthoquinone metabolite, which is common in Diospyros species. One report showed that
shinanolone exhibited anti-mycobacterial activity against M. tuberculosis at a concentration of
0.1 mg/mL and antibacterial activity against a variety of test organisms95,96.
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As mentioned before, the most common Diospyros naphthoquinone is 7-methyljuglone.
Isodiospyrin

(5-hydroxy-6-(1-hydroxy-6-methyl-5,8-dioxo-naphthalen-2-yl)-2-methyl-

naphthalene-1,4-dione) is a dimer of 7-methyljuglone linked between C-6 and C-8’. It was the
first compound isolated from the wood of Diospyros virginiana by Fallas and Thomson in 1968
97

and was reported to show significant cytotoxicity against the HCT-8 colon tumor, P-388

lymphocytic leukemiaK, HEPA-3B hepatoma, KB nasopharynx carcinoma, CLOL-205 colon
carcinoma and HeLa cervical carcinomaL. Isodiospyrin acts as a novel human DNA
topoisomerase I (htopo I) inhibitor through the ability to antagonize camptothecin-induced, htopo
I-mediated DNA cleavage and inhibits htopo I by direct binding to htopo I without access to the
DNA substrate

98

. Furthermore, isodiospyrin exhibits strong inhibitory effect on the kinase

activity of htopo I toward splicing factor 2/alternate splicing factor in the absence of DNA. Thus,
these findings have important implications on naphthoquinone and its derivatives’ cellular mode
of actions, i.e. these novel DNA topoisomerase I inhibitors can prevent both DNA relaxation and
kinase activities of htopo I.

Diospyrin is a plant-derived bisnaphthoquinonoid compound with less active properties than
its racemic isomer, isodiospyrin. It is a dimer of 7-methyljuglone linked between C-2 and C-3’.
Diospyrin has been used as a potential lead molecule to new drug against cancer as well as
several other diseases like leishmaniasis, trypanosomiasis, malaria and tuberculosis99, 100, 101, 102.
Diospyrin derivatives were found to be cytotoxic with the ability to generate reactive oxygen and
to induce apoptosis in human cancer cell lines 103.

Diospyros virginiana L. (named by Carl Linnaeus), also called American persimmon, is
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native to North America, and the fruits were reported to show cholesterol-lowering activity, and
usefulness to treat bloody stools, thrush, and sore throats

104

. The tree is common in the South

Atlantic and Gulf States, especially in the Mississippi River Vally. Traditional uses of the plant
include treatment of diarrhea and hemorrhoids, but today it is mainly used for culinary purposes.
Excessive consumption of the fruits can cause gastrointestinal disorder

105

. Many Diospyros

species are a rich source of triterpenes, naphthoquinones, and other naphthalene derivatives 92. A
literature research contains reports of eight compounds, including isodiospyrin, shinanolone
diospyrin, 7-methyljuglone

97

and scopoletin

106

92

,

isolated from the wood of D. virginiana, and

lupeol, betulin and betulinic acid isolated from the leaves of D. virginiana

107

. However, little

attention has been given to chemical fractions from the roots of D. virginiana.

The aim of this research was to identify naturally occurring active compounds with
antifungal activity against seven common plant pathogens. These include isolates of
Colletotrichum fragariae A. N. Brooks, Colletotrichum acutatum J. H. Simmonds, and
Colletotrichum gloeosporoides (Penz.) Penz. & Sacc., Botrytis cinerea Pers.: Fr, Fusarium
oxysporum Schlechtend: Fr, Phomopsis obscurans (Ellis and Everh.) B. sutton, and P. viticola
Sacc., which cause severe diseases to many crops each year, especially strawberry plants. In this
research program, we evaluated 37 plant extracts using a direct- bioautography bioassay to detect
antifungal activity against three Colletotrichum species. Of these, D. virginiana root extracts
showed the most promising activity. Based on preliminary screening results, a bioassay-guided
fractionation of D. virginiana root extract was conducted to isolate and identify the pure
metabolites possessing antifungal activity. A preparative overpressure layer chromatography
(OPLC) method was successfully used for the separation of two new natural compounds, 4-
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hydroxy-5, 6-dimethoxynaphthalene-2-carbaldehyde (9) and 12, 13-didehydro-20, 29dihydrobetulin (10) together with nine known compounds, including 7-methyljuglone (11),
diospyrin (12), isodiospyrin (13), shinanolone (14), lupeol (15), betulin (16), betulinic acid (17),
betulinaldehyde (18), and ursolic acid (19) from the acetone extract of the roots of D. virginiana.
Their identification was accomplished by 1D- and 2D-NMR (One Dimensional-and two
Dimensional- Nuclear Magnetic Resonance) spectroscopy and HR-ESI-MS (High resolution
electrospray ionization mass spectroscopy) methods. All the isolated compounds were evaluated
for their antifungal activities against Colletotrichum fragariae, C. gloeosporioides, C. acutatum,
Botrytis cinerea, Fusarium oxysporum, Phomopsis obscurans, and P. viticola using an in vitro
micro-dilution broth assay. The results indicated that compounds 3 and 5 showed high antifungal
activity against P. obscurans at 30 µM with 97.0 and 81.4% growth inhibition, and moderate
activity against P. viticola (54.3 and 36.6%). It appears that an optimized OPLC system offers a
rapid and efficient method of exploiting bioactive natural products.

2.1.2. Over Pressure Layer Chromatography (OPLC)
We should keep in mind that a single plant can contain up to several thousand secondary
metabolites, so high-performance and rapid separation methods are absolutely needed to be
emphasized 95. Several conventional methods including silica gel, polyamide and reversed-phase
liquid chromatography are often used to isolate pure compounds from natural plants, but they are
tedious, time-consuming, and require multiple chromatographic steps

108

. Overpressure layer

chromatography (OPLC) with a programmable pump equipped to deliver the mobile phase
overcomes the problems stated above. OPLC was developed by Tyihák and Mincsovics in the
late seventies 109. A TLC plate is covered by a sheet of flexible material in OPLC and subjected
to a high external pressure (Figure 2.1). The high external pressure generated by the
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programmable pump pushes the mobile phase through the analytical or preparative adsorbent
layer. This allows a faster separation and more compact spots than conventional TLC. Generally,
the separation distance of the compounds migrated over the adsorbent is two to five times greater
than in conventional TLC. Another advantage of OPLC is that it is a sealed system with less
solvent loss as a result of evaporation 110, 111. Therefore, the resolution is better than the obtained
by conventional TLC, especially in the lower and closer Rf range. Compared to conventional
methods, OPLC offers a more rapid and reliable method for the isolation of naturally occurring
compounds.

Figure 2.1 OPLC systerm (BIONISIS SA., Le Plessis-Robinson, France).

OPLC was widely used in analytical and preparative applications reported in previous
literature112, 113, 114, 115, 116. In the present paper, a preparative off-line OPLC technique was used
to isolate co-migrating compounds from the roots of D. virginiana using transfusion operation
(the chamber outlet is open during development). The difference between off-line and on-line
OPLC separations lies in the existence of a flow-cell detector. On-line OPLC usually couples to
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other chromatographic, electrophoretic, and spectroscopic techniques (e.g. OPLC-FTIR, OPLCUV, OPLC-MS, and OPLC-MALDI-MS). In off-line OPLC separation, there is no flow-cell
detector connected to the outlet and the eluent is detected by TLC analysis.

2.2 EXPERIMENTAL SECTION

2.2.1 Apparatus
OPLC: Personal OPLC 50 instrument (OPLC-NIT, Budapest, Hungary), at 50 bars
external pressure; OPLC silica gel (SiO2) layer, 60 F254 20×20 cm on glass plate (LG 011,
OPLC-NIT Ltd., Budapest, Hungary) with 200 µM sorbent thickness, 11 µM particle size, 6 nM
pore size, and 20×20 cm on aluminum sheet (BSLA 001, OPLC-NIT Ltd., H-Budapest) with
200µM sorbent thickness, 5 µM particle size, 6 nM pore size; an AS-30 sample applicator
(DESAGA, Wiesloch, Germany) was used for the sample application. TLC: Classical TLC
analysis was performed on silica gel 60 F254 20×20 cm on aluminum sheet (Gibbstown, New
Jersey, USA). Detection was carried out under UV light (254 and 366 nM), and visualization
with vanillin-H2SO4 (1 g of vanillin in 100 mL of 20% H2SO4 in EtOH) reagent, followed by
heating at 105 °C for 5 min. UV Spectra: Varian Cary 50 spectrophotometer; in MeOH; λmax (log
ε) in nm. IR Spectra: Bruker Tensor 27 spectrophotometer; ν in cm-1. 1H- and 13C-NMR spectra:
Bruker model AMX-500 and 400 NMR spectrometers with standard pulse sequences, operating
at 500 and 400 MHz for 1H, and 125 and 100 MHz for

13

C; δ in ppm rel. to Me4Si as internal

standard, J in Hz. High resolution electrospray ionization mass spectroscopy (HR-ESI-MS):
Micromass Q-Tof Micro mass spectrometer with a lock spray source; in m/z.
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2.2.2 Chemicals and Solvents
Silica gel column chromatography was performed with silica gel 60 (70-230 mesh, Merk).
Pre-coated aluminum silica gel 60 F234 20×20 cm plates (Merck) were used for classical TLC
analysis. ACS-grade solvents, acetonitrile (MeCN), acetone, dichloromethane (DCM),
chloroform (CHCl3), diethyl ether (Et2O), ethyl acetate (AcOEt), ethanol (EtOH), n-hexane,
isopropanol (iPrOH), methanol (MeOH), benzeneand toluene from Fisher Scientific (New Jersey,
USA) were used for SiO2 column chromatography (CC) and TLC separations. HPLC-Grade
solvents, acetonitrile (MeCN), chloroform (CHCl3), dichloromethane (DCM), and H2Ofrom
Sigma Aldrich (St. Louis, USA) were used for HPLC and OPLC chromatograms.

2.2.3 Plant Material
The roots of D. virginiana were collected from the Missouri Botanical Garden, USA, in
June 2009. The plant material was identified by Dr. Vaishali C. Joshi, and a voucher specimen
CON310700-2-A was deposited with the National Center for Natural Products Research, School
of Pharmacy, The University of Mississippi.

2.2.4 Extraction of the Plant Material
Dried powdered roots (66 g) were extracted in a Soxhlet extractor with acetone (600 mL)
for 8 h, and the extract was subsequently evaporated under vacuum to yield a dry residue (2 g).
The crude extract was fractionated on a SiO2 column (100 g, 50×5 cm, ChemGlass) using hexane
(500 mL), 5% AcOEt in hexane (600 mL), CHCl3 (600 mL), 5% iPrOH in CHCl3 (600 mL), and
MeOH (600 mL), resp. Four fractions were obtained in total, Fractions 1-4. Bioautographyguided assay showed that the activity was found to reside in fraction 1 (120 mg) and fraction 2
(240 mg), with some activity in fraction 3 (710 mg), while fraction 4 (800 mg) did not show any
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activity against three notorious plant pathogenic fungi of the Colletotrichum species. The active
fractions were subjected to bioassay directed isolation of the pure isolates (Figure 2.2).
Dried roots of D. virginiana
extracted with acetone for 8 h, dry
crude extracts
extracted with n-hexane (500 mL), 5% EtoAc in
n-hexane (600 mL), chloroform (600 mL), 5%
isopropanol in chloroform (600 mL) and
methanol (600 mL)

n-hexane
fraction

5% EtoAc in
n-hexane fraction

Chloroform 5% isopropanol in
Methanol
fraction
chloroform fraction fraction
(F-2)
(F-3)

OPLC isolation
combined
(F-1)

Compounds 9, 12, 13, 15, 18, 19

OPLC isolation

Compounds 10, 13, 14, 16, 17

Compound 11

Figure 2.1 Bioassay-guided fractionations of the acetone extract of Diospyros virginiana roots.

2.2.5 Isolation of Compound 11 (7-methyljuglone)
Fraction 1(120 g), which is the combination of n-hexane and 5% EtOAc in n-hexane
fractions contains two compounds with different Rf values. This fraction was applied to
preparative TLC plates and developed with chloroform-acetone (9:1, v/v) to yield one major
compound 11, 7-methyljuglone 114.

2.2.6 Selection of OPLC Conditions for Fractions 2 and 3
Fraction 2 (240 mg) and Fraction 3 (800 mg) were applied and purified by off-line
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OPLC-transfusion technique. In order to get good separation, many mobile phases (n-hexaneethyl ether, toluene-EtOAc, n-hexane-EtOH,n-hexane-EtOAc, DCM, DCM-MeOH, CHCl3acetone, CHCl3-EtOAc, n-hexane-EtOAc, DCM-EtOAc, EtOAc-n-hexane, DCM-ethyl ether,
CHCl3-MeOH, CHCl3-acetonitrile, CHCl3-isopropyl, toluene-EtOAc-n-hexane-formic acid) with
different ratios were tested and compared. Chromatographic results showed that two mobile
phases, DCM (100%) and n-hexane-ether (6/4, v/v) were preferred by Fraction 2 separation.
Four mobile phases, CHCl3-EtOAc (95/5, 98/2, v/v), n-hexane-ether (6/4, v/v), CHCl3acetonitrile (98/2, v/v) and toluene-EtOAc-n-hexane-formic acid (60:10:10:1, v/v/v/v) were
suitable for Fraction 3 purification.

2.2.7. Isolation of Compounds 9, 12, 13, 15, 18, 19 From Fraction 2 Using OPLC
A portion of Fraction 2 (20 mg) was purified by OPLC with DCM as the eluent. Elution
conditions were as follows: flash volume, 300 µL; eluent volume, 30,000 µL; flow-rate, 500 µL
min-1; development time, 3606 s; external pressure, 50 bars. 88 Subfractions (1 mL/fraction)
were obtained in total, of which sub-fractions 49–54 were detected as the same compound and
combined together to give betulinaldehyde (18) (0.8 mg), amorphous yellow solid. The structure
was identified by NMR spectroscopy and by comparison with reported data

117

. Sub-fractions

72–88 afforded ursolic acid (19; 1.3 mg), amorphous white solid. The structure was identified by
the comparison with previous data118. Sub-fractions 28–37 were combined to give a mixture of
three compounds (7.9 mg) and further purification was performed with n-hexane-ether (6/4, v/v,
20,000 µL; flash volume, 300 µL; flow-rate, 500 µL min-1; development time, 2406 s) as eluent
and 66 Sub-fractions were obtained, among which Sub-fractions 10’–18’ furnished lupeol (7;
2mg) by the spectroscopic data and previously study

119

. Sub-fractions 19’–66’ (marked as

Fraction A) were combined to give a mixture of 3.6 mg containing four compounds with close Rf
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values in several TLC systems (SiO2; hexane/EtOAct 3:2, CH2Cl2/iPrOH 9:1, CHCl3/MeOH
19:1). To obtain enough material (Fraction A) for further purification, OPLC procedures were
repeated six times under the same conditions, then Fraction A multiplied to 19.6 mg and then
was purified by OPLC with DCM (100%, 20,000 µL; flash volume, 300 µL; flow-rate, 400 µL
min-1 time, 3007 s). Sub-fractions 27”-33” were combined and identified as lupeol. Sub-fractions
12’’ was detected as pure on the TLC plate and showed yellow fluorescence under UV366. This
pure compound was identified as 4-hydroxy-5, 6-dimethoxynaphthalene-2-carbaldehyde (9;
1mg), which was reported here for the first time. Sub-fractions 9’’–11’’were combined and
submitted for NMR analysis. It was elucidated as diospyrin (12; 2 mg) and it was in agreement
with the previous data115. Sub-fractions 14”-21” were combined to give amorphous yellow solid
that was elucidated as isodiospyrin (13; 2 mg) by the NMR analysis and comparison to reported
data 114, 116.

2.2.8 Chromatograms of Pure Compounds 9, 12, 13, 15, 18 and 19
Off-line OPLC separation of Fraction 2 led to isolation of compounds 9, 12, 13, 15, 18
and 19 which correspond to 4-hydroxy-5, 6-dimethoxy-2-naphthaldehyde (9), diospyrin (12),
isodiospyrin (13), lupeol (15), betulinaldehyde (18), and ursolic acid (19). Four µL of 20 mg/mL
with 6 mm band size of compounds 9, 12, 13, 15, 18, 19 and Fraction 2 were applied at 30 mm
measured from the bottom edge of the adsorbent layer (200 × 200 × 0.2 mm). The distance
between two bands was 10 mm. OPLC infusion development (the outlet is closed) was
developed twice with DCM (100%, HPLC-grade) as eluent. The elution was conducted as
follows: volume of rapid eluent admission, 300 µL; development volume, 4887 µL; eluent flowrate, 400 µL min-1; development time, 740 s; external pressure, 39 bar. They were developed
twice with DCM (100%, HPLC-grade) using off-line OPLC infusion development and the
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chromatogram can be seen in Figure 2.3. Compound 1 showed yellow florescent under UV366.
Figure 2.3c showed that the compounds had very similar Rf values (19, 0.42; 18, 0.53; 13, 0.55;
15, 0.64; 9, 0.68; 12, 0.75) on the chromatogram, however, they were all nicely isolated from
each other by the application OPLC.
(a) UV 366 nm

f-2
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11
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(b) UV 254 nm
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f-2
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11
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1

(c) Vanillin-sulfuric acid reagent
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4
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1
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4

Figure 2.3 Chromatograms of off-line OPLC separation of six pure compounds from faction 2
under UV with developed by DCM (a & b), and visualized by vanillin-sulfuric acid plus heating
(c). The bold numbers represent the compounds in Figure 2.8.

2.2.9. Isolation of Compounds 10, 13, 14, 16, 17 From Fraction 3 Using OPLC
Fraction 3 (24 mg) was subjected to OPLC with CHCl3-AcOEt (95: 5, v/v, 40,000 µL)
with flash volume, 300 µL, flow rate, 500 µL min-1 and elution time 4806 s. One hundred and
twenty-three sub-fractions (1 mL/fraction) were collected in total. Sub-fractions 54–66 yielded
botulin

120

(16; 3.4 mg). Sub-fractions 10-22 were combined to give 2.3 mg of mixture of two

compounds and labeled as fraction B, which was further purified by n-hexane-ether (6/4, v/v)
using OPLC to yield isodiospyrin that was previously isolated in Fraction 2. Sub-fractions 67–90
were combined to give 7.4 mg of mixture containing two or three compounds and one of them
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showed yellowish-green fluorescence under UV366 and were marked as fraction C. Fraction C
was performed with 20,000 µL of toluene-EtOAc-n-hexane-formic acid (60/10/10/1, v/v/v/v)
solvent system with flash volume 300 µL, flow rate 250 µL min-1 and total elution time 4812 s.
Ninety-three sub-fractions were totally obtained and detected by TLC. Sub-fractions 18’-26’
were tested as the same compound that was elucidated as amorphous white solid, betulinic acid
121

(17). Fraction C (39 mg, multiplied by repeating the above OPLC procedures five times) was

purified using OPLC with CHCl3-acetonitrile (98/2, v/v) with flash volume 300 µL, flow rate
300 µL min-1 and total elution time 4806 s. Sub-fractions 79’-87’ were combined to give a
yellowish-green compound, which was identified as shinanolone

122

(14, 1.5 mg). The other

minor compounds were in such small quantities that they were impossible to isolate. To obtain
enough material for further purification, flash chromatography of fraction 3 (400 mg; BIOTAGE
(Isolera One); CHCl3/AcOEt (0–5%; 200 mL) and CHCl3 (100%, 201 mL–640 mL); flow rate, 5
mL min-1; Si, SNAP 25 g column) was conducted. A total of 81 sub-fractions (1 mL/fraction)
were collected. Sub-fractions 38 –51 were combined to yield a mixture (30 mg). This mixture
was subjected to the OPLC (CHCl3/MeCN 49: 1 (40,000 µL); flash volume, 300 mL flow rate,
250 mL/min total elution time, 9624 s). 183 Sub-fractions (1 mL/fraction) were obtained.
Subfractions 100–112 were combined and identified as botulin (16; 2mg). Sub-fractions 136–144
yielded betulinic acid (17; 1mg). Sub-fractions 114–126 gave the new triterpene, 12, 13didehydro-20, 29-dihydrobetulin (10; 1 mg) as a natural product 123.

2.2.10 Chromatograms of Pure Compounds 10, 13, 14, 16 and 17
Compounds 10, 13, 14, 16 and 17 represent 12, 13-didehydro-20, 29-dihydrobetulin (10),
isodiospyrin (13), shinanolone (14), betulin (16), and betulinic acid (17). They were developed
with CHCl3-acetonitrile (97:3, v/v) using off-line OPLC infusion development and the
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chromatogram is showed in Figure 2.4. Two µL of 20 mg/mL with 4 mm band size of
compounds 10, 13, 14, 16, 17 and fractions 3 were applied and the distance between two bands
was 8 mm. Off-line OPLC infusion development was developed with CHCl3-acetonitrile (97/3,
v/v, HPLC-grade) as eluent. The elution was conducted as follows: volume of rapid eluent
admission, 150 µL; development volume, 2787 µL; eluent flow-rate, 200 µL min-1; development
time, 843 s; external pressure, 39 bar. Compound 6 showed yellow-greenish color under UV366.
These co-migrating compounds had similar Rf values (17, 0.19; 14, 0.21; 10, 0.33; 16, 0.35; 13,
0.7). Particularly, compounds 10 and 16 had very similar Rf values on the OPLC plate. Forced
flow and longer development distances in the OPLC applications clearly revealed 10 and 16
separations with Rf values 0.33 and 0.35, respectively.

Figure 2.4 Chromatograms of off-line OPLC separation of five pure compounds from fraction 3
under UV with developed by CHCl3-acetonitrile (97:3, v/v) (a & b), and (c) visualized by
vanillin-sulfuric acid reagent plus heating.
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2.3 BIOLOGICAL EVALUATION

2.3.1 Direct-Bioautography

2.3.1.1 Pathogen production
Three Colletotrichum species including C. fragariae (isolate CF63), C. acutatum (isolate
CaGoff), and C. gloeosporioides (isolate CG162) obtained from Dr. B. J. Smith (USDA, ARS,
Small Fruit Research Station, Poplarville, MS) were used for direct-bioautography study. Isolate
CF63 is one of the most infective isolates infecting strawberry plants and causing both crown
and fruit rot

124

. CaGoff, CF63 and CG162 were used as standard test isolates because of our

comprehensive knowledge of these isolates and their fungicide sensitivity profiles in both
bioautography and microtiter formats.

2.3.1.2 Inoculum preparation
Fungal cultures were initiated on ½ strength potato dextrose agar (PDA, Difco, Detroit
MI) from spores stored in sterile 10% glycerol RPMI (Roswell Park Memorial Institute, Gibco)
buffer with MOPS (3-(N-morpholino) propane sulfonic acid) at -80°C. Fifty µL suspended spore
solution was inoculated on PDA plate using crossed inoculation method. Inoculated plates were
incubated at 24 ±  2°C under cool-white fluorescent lights (55±5 µmols/m2/s1) with a 12 h
photoperiod. Colletotrichum cultures were subcultured or harvested from PDA every 7-10 days.
Conidia were harvested by flooding plates with 3-5 mL of sterile distilled water and dislodging
conidia by softly brushing the colonies with an L-shaped glass rod. Conidial suspensions were
filtered through sterile Miracloth (Calbiochem-Novabiochem Corp., La Jolla, CA) spread on a
sterile funnel to remove mycelia. Conidia suspensions were adjusted with sterile distilled de-
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ionized distilled (DDI) water to a concentration of 1.0 × 106 CFU (colony forming units)/ mL (19,
20). Conidia concentrations were determined photometrically from a standard curve based on the
percent of transmittance (%T) at 625 nm. Conidial suspensions of each Colletotrichum species
(CF63, CaGoff and CG162) were then adjusted to a concentration of 3.0×105 conidia/mL with
liquid potato-dextrose broth (PDB, Difco). Using a chromatographic sprayer, each 250 µM silica
Gel GF Uniplate (Analtech, Inc. Newark, DE) thin-layer chromatography (TLC) plate was
sprayed lightly (to a damp appearance) three times with the conidial suspension 125.

2.3.1.3. Bioautography
Antifungal compounds were indicated by inhibition of fungal growth on chromatographic
plates using modifications of TLC bioautographic assays

126, 127, 128

. The acetone extract of D.

virginiana roots was dissolved in chloroform at 20 mg/mL concentrations. Using a disposable
glass micropipette for each sample, 4 µL and 8µL of each test compound were placed on the TLC
plate in a grid format to achieve a final amount of 80 and 160 µg/spot.

To detect biological activity directly on the TLC plate, silica gel plates were sprayed with
either of the three spore suspensions. Inoculated plates were placed in a 30 cm×13 cm×7.5 cm
398-C moisture chamber (Pioneer Plastics, Inc. Dixon, KY) and incubated in a growth chamber
at 24±1°C and 12 h photoperiod under 60±5 µmols/m2/s1light. Inhibition of fungal growth was
observed 4 days after treatment. Sensitivity of each fungal species to each test compound was
determined by comparing the size of inhibitory zones.
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Technical fungicide grade standards benomyl, cyprodinil, azoxystrobin, and captan
(Chem Service Inc., West Chester, PA) were used as positive controls at 2 mM in 2 µL of 95%
ethanol. Benomyl (a benzimidazole inhibitor of microtubule formation) and captan (a phthalimid
with multisite inhibition) are the commercial fungicides labeled for control on strawberry
anthracnose. Azoxystrobin (a methoxyacrylate preventing the generation of ATP) is
commercially used to control Colletotrichum and Botrytis diseases. Cyprodinil (a methionine
biosynthesis inhibitor) is mainly used for control of cereal diseases and of Botrytis spp. on grapes
and vegetables

129

. For the antifungal assay 20 mg/mL of crude extracts or semi-purified

fractions were applied to precoated Si gel TLC plates, developed with CHCl3, and dried for
complete removal of solvents. The chromatograms were sprayed with a spore suspension of C.
fragariae, C. acutatum, and C. gloeosporioides in potato dextrose broth (PDB) and incubated for
4 days in a moistened chamber at 25 °C, following the previously reported procedure (Figure
2.5). The result showed that mild polar compounds appear to be responsible for antifungal
activity.
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Figure 2.5 Bioautogrphic results of root crude extracts and fractions of Diospyros virginiana.
Diospyros virginiana (D-1) root extracts showed promising antifungal activity against three
Colletotrichum species. Fraction 1-3 exhibited antifungal activity against plant pathogens, and
Fraction 4 did not exhibit any activity.

2.3.2 Microtiter Assay
A standardized 96-well micro-dilution broth assay developed by Wedge and Kuhajek

130

was used to evaluate the antifungal activity of pure compounds from D. virginiana that were
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identified as active by bioautography (Figure 2.6)

MICROTITER ASSAY
Experimental Design
Botrytis cinerea
0.3 µM

3.0 µM

30 µM

Control

20 µl fungicide sln
+
80 µl RPMI buffer
+
100 µl conidial susp

A
B
C
D
E
F

Incubate plate 0 – 72 h

G

Read absorbency at 620 nm
in microplate photometer

H

Blank

Blank

Blank

Blank

Figure 2.6 Experimental design of a standardized 96-well micro-dilution broth assay.

Isolates of C.acutatum, C. fragariae, C. gloeosporioides, B. cinerea, F.oxysporum, P.
obscurans, and P. viticola were used to evaluate the antifungal activity of the test compounds
using in vitro micro-dilution broth assay. Each fungus was challenged in a dose-response format
using test compounds where the final treatment concentrations were 0.3, 3.0 and 30.0 µM.
Technical grade commercial fungicides captan, azoxystrobin, and benomyl, which represent
three different modes of actions, were used as positive fungicide standards. Each compound was
evaluated in duplicate and the experiment was performed three times in time. Mean absorbance
and standard errors were used to evaluate fungal growth after 48 and 72 h, except for P.
obscurans and P. viticola (120 and 144 h).
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2.4 RESULTS AND DISCUSSION
The roots of D. virginiana were extracted with acetone in a Soxhlet extractor. The
constituents of this extract were mainly separated by OPLC. An OPLC system is considered as
the bridge between TLC and HPLC, which uses a programmable pump to push the mobile phase
through the “flat column” and the forced flow leads to a faster separation and improved
efficiency than capillary flow. Furthermore, the use of longer separation distances increases zone
capacity compared to conventional TLC. OPLC offers a sealed system where compounds can be
developed with less solvent in less time. OPLC stands out from a number of isolation techniques
due to its flexibility to stop the elution process and visualize the separation of compounds under
UV during the process of development. According to observation result, we can decide to
continue the elution and/or change the elution solvent or convert a double-development method.
Rapid speed of elution through OPLC columns limits the diffusion effects of the compounds,
making the separation of closely related compounds more purified than the one from classical
TLC, thereby concentrating bioactive compounds into a smaller more concentrated zone or band
and thereby enhancing direct bioautography detection sensitivity. Another advantage of OPLC is
that the eluent flow rate is adjustable through the adjustment of three different solvent systems
(A, B, and C) for isocratic or step-wise gradient runs131, 132, 133. However, the OPLC column has
to be used in right direction. Figure 2.7 showed the conditions of OPLC chromatogram for
Fraction 2 and its compounds in two directions (A & B). Apparently, B showed a longer and
cleaner separation among compounds, which indicates that the right developing direction of
OPLC plate needs to be emphasized. OPLC coupled with direct-bioautography offers a powerful
tool to separate co-migrating bioactive compounds for the discovery of natural product for pest
management.
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Figure 2.7 Fraction 2 and its pure compounds.

A new naphthalene derivative, 4-hydroxy-5, 6-dimethoxynaphthalene-2-carbaldehyde (9),
and a triterpene, 12,13-didehydro-20, 29-dihydrobetulin (10) were isolated from a natural source
for the first time, along with nine known compounds, 7-methyljuglone (11), diospyrin (12),
isodiospyrin (13), shinanolone (14), lupeol (15), betulin (16), betulinic acid (17), betulinaldehyde
(18), and ursolic acid (19). Although they are common in most of the Ebenaceae family

45

,

compounds 18 and 19 were isolated for the first time from D. virginiana. The structures of the
known compounds were confirmed by comparison of their spectroscopic data (1H- and 13C-NMR,
and MS) with literature values (Figure 2.8).134
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Figure 2.8 Isolated compounds from the roots of Diospyros virginiana.
The HR-ESI-MS of compound 1 indicated a molecular formula C13H12O4, and its IR
spectrum exhibited characteristic absorption bands for OH and conjugated C=O groups. The 1HNMR spectrum showed signals for an CHO group at δ (H) 10.03 ppm, and an aromatic AB
system at δ (H) 7.37 (d, J=9.0) and 7.78 (d, J=9.0). These data suggested a naphthalene-2carbaldehyde structure with two MeO groups (δ (H) 4.06 and 4.13 ppm), and an OH substituent
(δ (H) 9.75 ppm). The 13C-NMR spectrum showed 13 signals of which ten were typical aromatic
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C-atoms. Assignment of structure was accomplished by HMBC experiment. The NOESY
experiment showed a correlation between the MeO group signal at δ (H) 4.06 and H-C (7) signal
(δ (H) 7.37 (d, J=9.0 Hz)), and MeO signal at δ (H) 4.13 and the OH signal at δ (H) 9.75 ppm,
corroborating the location of the MeO groups at C (5) and C (6). Thus, 9 was characterized as 4hydroxy-5, 6-dimethoxynaphthalene-2-carbaldehyde.

Compound 10 was obtained as a white solid. The molecular formula was determined as
C30H51O2 by HR-ESI-MS (m/z443.3874 ([M+H]+)). The

13

C-NMR data of 10 indicated the

presence of 30 C-atoms comprising seven CH3 groups, ten CH2 groups, seven CH groups, and
six quaternary C-atoms. TheCH3 groups resonated at δ (H) 0.79 (s, 6 H), 0.93 (d, J=6.8, 6 H),
0.98 (s, 3 H), 0.99 (s, 3 H), and 1.10 (s, 3 H) in the 1H-NMR spectrum, indicating the lupane
triterpene skeleton for 10 135. The 13C-NMR spectrum also revealed the presence of one olefenic
CH group (δ(C) 125.0), which correlated in the HMQC spectrum with the H-atom at δ (H) 5.20
(H-C (12)). The latter H-atom showed HMBC correlation with C (9), C (14), and C (18),
evidencing the C (12)=C (13) bond. This was confirmed by the COSY correlation between H-C
(12) (δ (H) 5.20) and CH2 (11) (δ (H) 1.90), and further supported by the HMBC correlation of
Me (27) (δ (H) 1.10) and C (13) (δ(C) 136.7) (Figure 2.9). From these data, the compound 10
was deduced to be 12,13-didehydro-20, 29-dihydrobetulin. This is the first report of 10 from a
natural source together with its full spectral data, although it has been prepared synthetically, and
only the 1H-NMR data were reported 123.
4-hydroxy-5, 6-dimethoxynaphthalene-2-carbaldehyde (9): Yellow amorphous solid; UV
(MeOH): λmax nm (log ε): 375 (4.1), 320 (4.2), 270 (3.8); IR (neat): νmax 3332, 2923, 2851, 2360,
2341, 1687, 1372, 1274, 1055 cm-1; 1H- NMR (500 MHz, CDCl3): δ 4.06 (3H, s, OMe), 4.13
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(3H, s, OMe), 7.29 (1H, s br, H-C (3)), 7.37 (1H, d, J= 9.0 Hz, H-C (7)), 7.78 (1H, d, J=9.0 Hz,
H-C (8)), 7.81 (1H, s br, H-C (1)), 9.75 (1H, OH-C (4)), 10.03 (1H, s, H-C (11)); 13C-NMR (125
MHz, CDCl3): δ 56.67 (OMe), 62.20 (OMe), 106.14 (C(3)), 115.46 (C(7)), 121.49 (C(10)),
126.02 (C(1)), 127.19 (C(8)), 130.120 (C(9)), 134.09 (C(2)), 143.46 (C(5)), 149.95 (C(6)),
154.28 (C(4)), 191.79 (C(11)); HR-ESI-MS: m/z =233.0812 ([M + H]+,

C13H13O4; calc.

233.0814).

12,13-didehydro-20,

29-dihydrobetulin

(=(3β)-Lup-12-ene-3,

28-diol;

10):

White

amorphous solid; [α]20D = +79.2 (c 0.05, MeOH ); IR (KBr): νmax 3340, 2940, 2867, 1446, 1372,
1027 cm-1; 1H-NMR (400 MHz, CDCl3): δ 0.73 (1H, d, J=7.2 H-C(5)), 0.79 (6H, s, Me-24, Me26), 0.89 (1H, m, , H-C(20)), 0.93 (6H, d, J= 6.8 Hz, Me-29, Me-30), 0.98 (3H, s, J=9.0 Hz, Me25), 0.99 (3H, s, Me-23), 1.10 (3H, s, Me-27), 1.20-1.81 (8CH2), 1.90 (2H, m, H2-C(11)), 3.19
(1H, d, J=10.4, H-C(28ª)), 3.22 (1H, m, H-C(3)), 3.53 (1H, d, J=10.4, H-C(28b)), 5.13 (1H, br. s,
H-C(12)); 13C NMR (100 MHz, CDCl3): δ 15.6 (C(29)), 15.7 (C(24)), 16.7 (C(25)), 17.3 (C(26)),
18.3 (C(6)), 21.3 (C(30)), 23.2 (C(21)), 23.3 (C(27)), 23.4 (C(11)), 25.9 (C(2)), 27.2 (C(15)),
28.1 (C(23)), 30.6 (C(16)), 32.8 (C(7)), 35.2 (C(1)), 36.9 (C(14)), 38.7 (C(22)), 38.0 (C(4)), 39.3
(C(20)), 39.4 (C(19)), 40.0 (C(10)), 42.0 (C(8)), 42.3 (C(17)), 47.6 (C(18)), 54.0 (C(9)), 55.1
(C(5)), 69.9 (C(28)), 79.0 (C(3)), 125.0 (C(12)), 136.7 (C(13)). HR-ESI-MS m/z = 443.3874 ([M
+ H]+, C30H51O2; calc. 443.3889).
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Figure 2.9 Relevant 1H-13C HMBC (→) and 1H-1H COSY (↔) correlations of 10.

The antifungal activities of compounds 9-19 were evaluated using a 96-well microdilution broth assay against the plant pathogens B. cinerea, F. oxysporum, P. obscurans, P.
viticola, and three Colletotrichum species. Phomopsis species were the most sensitive fungi to
these compounds. 7-Methyljuglone (3) and isodiospyrin (5) showed the highest antifungal
activities against P. obscurans. Compound 3 showed 97.0% growth inhibition of P. obscurans at
30 µM at 120 h, whereas compound 5 showed 81.4% growth inhibition. The antifungal activities
of 11 and 13 at 30 µM against P. viticola were 53.4 and 57.7%, respectively.

The new compounds 4-hydroxy-5, 6-dimethoxynaphthalene-2-carbaldehyde (9) and 12,
13-didehydro-20, 29-dihydrobetulin (10) at 30 µM showed weak antifungal activities with 26.9
and 22.1%, respectively (Figure 2.10). Compounds 11 and 13 at 30 µM caused 54.3 and 36.6%
growth inhibition of P. viticola at 120 h. Any test compound possessing < 50% growth inhibition
at 30 µM is considered to have a weak antifungal activity in this bioassay. Compound 9 was
more active against P. viticola at 120 h than at 144 h. This response is often observed when an
inducible enzyme system is turned on, and a compound is detoxified by the fungus. However, the
upward slope of the graph for compound 9 in Figure 2.11 from the low to high concentration
may be indicative of precipitation in the aqueous micro-dilution broth assay (there is not enough
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amount of compound 9 for another microtiter assay). Because the microtiter plate reader
measures changes in optical density, it does not discriminate between fungal growth and
precipitation. Compound 9 appears to have come out of solution at the higher concentration (30
µM) in the P. viticola testing (Figure 2.11). Lipophilic compounds are problematic in in vitro
aqueous bioassays, and follow-up antifungal testing will take place using a detached leaf
bioassay

136

. The graphical results indicated that compounds 10, 11, and 13 appear to remain

soluble at 120 and 144 h. Commercial fungicides captan and benomyl are significantly more
active than any of the compounds tested. Azoxystrobin, which is commercially used to control
Colletotrichum and Botrytis diseases, shows poor activity against P. viticola. Both captan and
azoxystrobin show 100% growth inhibition at 3 µM against P. obscurans. Although once an
excellent agent for controlling anthracnose and other diseases of strawberries and ornamentals,
resistance developed by pathogens has resulted in benomyl being less useful

137

. While the test

compounds appear inherently antifungal, we hypothesize that these compounds are probably
present in the plant as constitutive defense compounds that act to deter infection or fungal
growth. Since these compounds were found without elicitation, they are probably constitutive in
nature 138,139 and may have a potential role in preventing fungal infection in D. virginiana.
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Figure 2.10 Mean fungal growth inhibition (%) of Phomopsis obscurans after exposure to 1, 2, 3
and 5 using a dose-response format at 120 and 144 h was noted. Abreviations used are: Cap:
Captan; Azo: Azoxystrobin; Ben: Benomyl. The bold numbers represent the compounds in
Figure 2.6. (1: Compound 9; 2: Compound 10; 3: Compound 11; 5: Compound 13.
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Figure 2.11 Mean fungal growth inhibition (%) of Phomopsis viticola after exposure to 1, 2, 3
and 5 using a dose-response format at 120 and 144 h was noted.
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2.5 CONCLUSION
Using a bioassay-guided fractionation of the acetone extract D. virginiana, we isolated
the antifungal constituents of the roots of this plant. This research demonstrates that OPLC is a
powerful technique that can be used to separate and isolate co-migrating natural products
produced by plants. These constituents were tested for the first time against Colletotrichum spp.,
B. cinerea, F. oxysporum, P. obscurans, and P. viticola. The most promising agricultural lead
compounds against the pathogen P. obscurans are compounds 11 and 13. Phomopsis leaf blight
and fruit rot is a serious disease with strawberries and causes serious economic loss of this fruit
each year. Our results suggest that compounds 11 and 13 warrant further in vivo testing as plant
protectants or leads to control Phomopsis species 136.
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CHAPTER 3 ISOLATION OF ANTIFUNGAL METABOLITES FROM TWO
ISOLATES OF CLADOSPORIUM CLADOSPORIOIDES

3.1 INTRODUCTION

3.1.1 Cladosporium spp.
Cladosporium spp., one of the largest genera of dematiaceous hyphomycetes, is widely
distributed throughout the world especially in the tropics and subtropics 140. It contains more than
30 species and 772 names 141, and the most common species include C. elatum, C. harbarum, C.
spherospermum and C. cladosporioides

142

. Species belong to Cladosporium are not

characterized by common taxonomic classification due to their lack of sexual reproduction, and,
hence are grouped into Fungi imperfecti

143

, in which fungi produce their spores asexually.

Identification and differentiation of the species of this genus are based on morphological and
molecular methods. This genus is characterized by having a unique coronate scar structure
and by being linked to Davidiella teleomorphs

145, 146

144

,

. Colonies of Cladosporium were reported

to have a unique color ranging from olive-green to greenish brown on PDA. They grow
relatively slowly, but sporulate abundantly, giving the colonies a dusty, velvety appearance 147.

Cladosporium spp. is considered as the most isolated fungi in nature and can be found on
dead plants, contaminated food, straw, soil, colors, and textile
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143

. Cladosporium rot in wine

grapes was the common disease induced by two species, C. cladosporioides and C. herbarum 148.
Besides plants, Cladosporium spp. can also be pathogenic and toxigenic to humans. So far,
research literatures have recorded cases of cerebral phaeohyphomycosis, cutaneous infections,
onychomycosis, sinusitis and pulmonary infections caused by Cladosporiumspp

143

. In addition,

spores of this genus are easily spread in air and cause serious allergic diseases to respiratory tract
mucosa or asthma as well as intrabronchial lesions 149, 150.

3.1.2 Cladosporium cladosporioides
Cladosporium cladosporioides (Fresen.) de Vries is a very common saprophytic fungus
in this genus which can contaminate many types of seeds. It is the pathogen of many different
host plants and can be isolated from many sources including air, soil, textiles and several other
substrates 151. In a direct-bioautography assay, C. cladosporioides are usually one of the adopted
indicator organisms used for the detection of antifungal fractions and compounds in the
bioassay-guided isolation

152, 153, 154, 155

. C. cladosporioides has also been involved in several

human diseases causing pulmonary constrictions (asthma and pulmonary emphysema) and
cutaneous infections (phaeohyphoomycosis)

149, 156, 157, 158

. In 2002, C. cladosporioides was

reported to exist in three cerebrospinal fluid specimens and a brain biopsy specimen of a human
patient

159

. Currently, 34 strains of C. cladosporioides have been isolated and identified from

different sources 140. A strain refers to a genetic variant of the same species. So one fungus could
have a variety of strains under the same species name. Plant extracts have been considered to be
ideal candidates for treating fungal infections. However, besides plant extracts natural occurring
microorganisms can also be useful in the control of plant pathogens, such as Penicillium and
Trichoderma. Recently, one invention reported that an isolate of C. cladosporioides was very
effective in both prevention and treatment of pathogen caused diseases on plant issues, such as
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apple scab (Venturia inaequalis)

160

. A particular isolate of C. cladosporioides combined with

benzoic acid was effective against Plasmopara viticola by 81.27% growth inhibition
isolate has been used for fungus infections caused by Botrytis and Fusarium species

161

162

. An

. More

interestingly, C. cladosporioides has been widely used for biosorption of gold or silver from
solutions163. A fungal isolate C. cladosporioides 1 was found to possess preferential metal
binding properties and could efficiently adsorb gold and silver metals from a mixture which
contain other metals including zinc, cadmium, chromium, nickel and copper

163

. Another isolate

C. cladosporioides 2 could remove zinc, cadmium, chromium, nickel and copper in addition to
gold and silver 164. One report showed that C. cladosporioides was employed as reductant in the
extracellular biosynthesis of silver nanoparticles (AgNP) 165 (Figure 3.1).

Figure 3.1 Conidiophores of Cladosporium cladosporioides sprouting from agar with all types of
dispersion structures140.

The pathogenicity and toxicity that C. cladosporioides produces to plants or human are
normally attributed to the toxic secondary metabolites they produce. C. cladosporioides produces
very active compounds, such as cladosporin and emodin, as well as some other less toxic
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metabolites. Fungal secondary metabolites are bioactive compounds that are produced as
families of related compounds during the stationary phase of growth and are usually of low
molecular weight. Some famous fungal secondary metabolites are known as penicillin,
cephalosporin, ergotrate and statins

166, 167

. Secondary metabolites do not appear to participate

directly in fungal growth and development, but are involved in the interactions between fungi
and their environment. In contrast, primary metabolites, such as vitamins, phytosterols, acyl
lipids, nucleotides, amino acids, and alcohols are directly involved in normal fungal growth,
development, and reproduction. In addition, primary and secondary metabolites have similar
precursor molecules, chemical structures and biosynthetic origins

168

. Bioactive secondary

metabolites that have been isolated from C. cladosporioides include cladosporin (20)
isocladosporin (21)

170

, cladospolides A (22) and B (23)

calphostins (25) 173 (Figure 3.2).
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Figure 3.2 Structures of compounds isolated from C. cladosporioides by previous studies.

3.1.3 Biological and Chemical Study of Cladosporin

3.1.3.1 Biological activities of cladosporin
Cladosporin (20) (also known as asperentin), 3,4-dihydro-6, 8-dihydroxy-3-(6-methyl
tetrahydropyran-2-ylmethyl) isocoumarin, is an important secondary metabolite derived from C.
cladosporioides in 1971. It is a major compound of C. cladosporioides but a minor metabolite of
other fungal sources including Aspergillus flavus
truncata

177

, Chaetomium globosum

178

174

, Aspergillus repens

, and several Eurotium species

antifungal and antibacterial properties, as well as insecticidal activity

175, 176

176

, Oidiodendron

. It showed specific

170, 179

. It was reported to

inhibit the spore generation of Penicillum and Aspergillus species at ≤ 40 µg/mL, and uracil and
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leucine uptake into Bacillus brevis cells

171

. Also, it completely inhibited the growth of several

dermatophytes in vitro at 75 µg/mL169. Xie, et al., found that cladosporin exhibited antifungal
activity against Escherichia coli, Rhizoctonia solani, Trichoderma viride and Colletotrichum
cameliaeet al. at a concentration of 100-200 µg/mL

180

. Cladosporin was shown to be a plant

growth inhibitor by Springer and Cutler in 1981, which inhibited the growth of etiolated wheat
coleoptiles at 10-3, 10-4, and 10-5 M

175

. Later in 1994, cladosporin was tested for antitumor

induction in an Agrobacterium tumefaciens potato disc assay and it showed -79% antitumor
induction

181

. Due to these statistics, cladosporin has been considered as a promising novel

fungicide.

3.1.3.2 Stereochemistry of cladosporin
Cladosporin was crystallized from methanol as pale yellow crystals and soluble in
ethanol, and ethyl acetate, moderately soluble in chloroform, slightly soluble in benzene, and
insoluble in hexane and water 169, 182. Its stereochemistry was completely assigned through X-ray
diffraction by Vederas, Cutler and other researchers at Merck (Figure 3.3) 175, 183.
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Figure 3.3 The crystalline structure of cladosporin.

As Figure 3.3 showed, the absolute configuration of three chiral carbons, C8, C4 and C5,
need to be established. The stereochemistry of C8 was determined as R by circular dichroism
(CD) analysis, which showed an opposite curve to that given by a known compound

174

.

Subsequently, the X-ray structure assigned the stereochemistry of the tetrahydropyran ring at C4
(S) and C5 (R) 175. The X-ray data was described in page 72.

3.1.3.3 Biosynthesis of cladosporin
Biosynthesis of cladosporin involves assembly of basic two carbon units from acetate and
malonate through acetate-malonate (AA-MA) pathway, which is an important pathway in the
biosynthesis of polyketides and fatty acids

184

. The formation of polyketides closely resembles

the biosynthesis of long chain fatty acids 185. This pathway involves a series of Claisen reactions
in which two molecules of acetyl-CoA react in a Claisen condensation to give acetoacetyl-CoA,
and then repeated to generate a poly-β-keto ester of required chain length (Figure 3.4).
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Figure 3.4 The formation of the poly-β-keto chain by claisen condensation.

In 1973, Grove and the co-workers reported the biosynthesis of cladosporin (II, Figure
3.5) in an entomogenous strain of Aspergillus flavus by incorporation of [1-13C] acetate and [214

C] malonte

186

. This labeling experiment confirmed the biosynthetic pattern of cladosporin

from a precursor (I, Figure 3.5) consisting of one acetate-derived initiating unit and seven
malonate-derived two-carbon building units (Figure 3.5).

* 2R
* 2R + 7 CH2 (CO2H)CO
MeCO
O

*
O

*

* 2H
CO
O

O

*

*

O

*
*O O*

7

HO

Me

OH O
8a C*

*

* *4a
5

1

*

O

3

*

2'

1'

5'
6'

* O * Me

(II) cladosporin

(I) precursor

Figure 3.5 Biosynthesis of cladosporin ring system from acetate and malonate units.
3.1.3.4 Total synthesis of cladosporin
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Recently, the asymmetric total synthesis of cladosporin was just reported by Chinese
scientists in Lanzou University

187

. They started the synthesis in 8 steps from tetrahydropyran

(THP), which was found in numerous biologically active natural products. Cladosporin (20)
bears a 2, 6-disubstituted tetrahydropyran (THP) ring and a δ-valero lactone with a fused 1, 3dihydroxybenzene ring. The synthesis started with 28, which was generated from ring-open of
oxide 27. Treatment of allytrime-thylsilane in the presence of a catalytic amount of TMSOTf led
to 29, which had 2,6-trans-THP selectivity. Enantioenriched epoxide 30 was obtained by mCPBA epoxidation of alkene 29. After treatment with the Grignard reagent and CuI at -30 °C,
epoxide 30 was reduced to alcohol trans-4. The lactone 32 was furnished from trans-4 through
two reactions including oxa-Pictet-Spengler cyclization and Jones oxidation. After removal of
both aromatic methyl ether groups under Maier’s conditions, lactone 32 was converted to
cladosporin (Figure 3.6).
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Figure 3.6 Total synthesis of cladosporin 187.
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3.1.4 Biological and Chemical Study of Isocladosporin
Isocladosporin (21) is a diastereoisomer of cladosporin at C-14 (or C-6’), and was
188

isolated from C. cladosporioides in 1993

. The absolute configuration of natural

isocladosporin has not been deduced. There exist two solution-state conformations (see Figure
3.7) that were proposed by Jacyno in 1993

188

. In 2012, She, et al., synthesized the

isocladosporin and proved that the relative configuration of isocladosporin was supposed to be
the structure of (21. a) (Figure 3.7), because the physical properties of (21. b) was different from
that of natural isocladosporin isolated by Jacyno

187

. Isocladosporin was tested to be slightly

more potent than cladosporin in the etiolated wheat coleoptile bioassay, producing 100% growth
inhibition, compared to 81% for cladosporin at 10-3 M 188.
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Figure 3.7 Two solution-state conformations (a & b) of isocladosporin. In structure b, H-11
protons have been omitted for clarity.

3.1.5 Other Compounds Isolated From C. cladosporioides
Other compounds isolated from C. cladosporioides include cladospolides A (22) and B
(23), cladosporol (24), and the calphostins (25). Cladospolides A (22) and B (23) are two
geometrical isomers that were isolated by Hirota and co-workers in 1981 and 1985 respectively.
It is interesting to know that both isomers showed different biological activities--cladospolides A
acted as a root growth inhibitor of lettuce seedlings, while cladospolides B acted as a root growth
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promoter of lettuce seedlings 189, 190. In 1995, one more bioactive metabolite was isolated from C.
cladosporioides elucidated as cladosporol (24), which was a β-l, 3-glucan-biosynthesis inhibitor
due to its epoxy-alcohol structure 172. A complex of Calphostins (25) (A, B, C, D, I) was isolated
from C. cladosporioides by Japanese scientists in 1989. These calphostins showed potent and
specific inhibitory activity against protein kinase C (PKC), with emphasis of calphostin C that
specifically inhibited PKC at 0.05 µM 173.

3.2 THE AIM OF THIS RESEARCH
In summary, fungi provide an abundant source of natural products that may have
potential agricultural, environmental, and pharmaceutical use. In the course of discovery of
bioactive metabolites from fungus extracts, 40 fungi crude extracts were screened using a directbioautography coupled Colletotrichum bioassay. Eight extracts were identified as active. Two of
the extracts, the acetone extracts of Cladosporium cladosporioides NRRL 5507 and another
isolate of C. cladosporioides (labeled as Miligrante) showed the most promising activities
against three Colletotrichum species (Figure 3.8). To our best knowledge, there are no reports on
the antifungal activity of C. cladosporioides against the three Colletotrichum species. The crude
extracts, fractions, and pure compounds of C. cladosporioides were also tested for cannabinoid
and opioid receptor activity. Based on the encouraging biological effects, the isolation and
purification of the crude extracts of this species was initiated.
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Figure 3.8 Bioautographic results of two isolates of C. cladosporioides against three
Colletotrichum species. The first row showed the result of isolate 1 (C. cladosporioides NRRL
5507) and the second row showed the result of isolate 2 (Milogrante).

3.3 BIOLOGICALLY ACTIVE COMPOUNDS FROM CLADOSPORIUM
CLADOSPORIOIDES NRRL 5507

3.3.1 Results and Discussion
Bioassay-guided fractionation of C. cladosporioides crude extracts led to the isolation of
six compounds, including the major constituent cladosporin (20) (5.038 g), isocladosporin (21)
(8.3 mg), 5’-hydroxyasperentin (33) (117 mg), asperentin-8-methyl ether (34) (3 mg), palmitic
acid (36) (10 mg) and linoleic acid (8 mg) (37). And the compound, 6, 5’-diacetyl cladosporin
(35) (4.5 mg) was synthesized based on pyridine-catalyzed acetylation of compound 33 (Figure
3.9). The chemical structures of these compounds were established on the basis of extensive 1D
and 2D NMR and HRESIMS data. Cladosporin, as a major component, was crystallized from
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three fractions, Hex/EtOAc (25:75), Hex/EtOAc (50:50), and EtOAc(100%) fractions as pale
yellow crystals. The absolute stereochemistry of cladosporin was validated by single-crystal Xray. Compounds 33 and 34 were isolated from Aspergillus flavus 174, Chaetomium globosum 178
and Eurotium repens before 179 but they were isolated for the first time from C. cladosporioides.
The stereochemistry of 5’-hydroxyasperentin (33) at C-5’ was confirmed for the first time on the
basis of NOE data. Pure compounds were submitted for antifungal activities against seven plant
pathogens. Phomopsis viticola was the most sensitive fungus to the test compounds. Phomopsis
viticola is a plant pathogen that causes severe disease of grape often known as Phomopsis cane
and leaf spot disease of grape. At 30 µM, Cladosporin (20) exhibited 92.7%, 90.1%, 95.4% and
83.0% growth inhibition against C. acutatum, C. fragariae, C. gloeosporoides and P. viticola,
respectively. Isocladosporin (21) showed 50.4%, 60.2% and 83.3% growth inhibition at 30 µM
against C. fragariae, C. gloeosporoides and P. viticola, respectively. Cladosporin exhibited
antifungal activity against Cryptococcus neoformans with IC50 value of 17.72 µg/mL.
Furthermore, in herbicidal bioassays, cladosporin has moderate to high monocot herbicide
activity against Agrostis but no dicots herbicide effect against Lettuce.
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Figure 3.9 Compounds isolated from Cladosporium cladosporioides NRRL 5507.

3.3.2 Biological Evaluation

3.3.2.1 Antifungal activity against plant pathogens (Microtiter Assay)
Pure compounds were further evaluated for their antifungal activity using an in vitro microdilution broth assay. Compound 20 showed significant antifungal activities and at 30 µM caused
92.7 % growth inhibition of C. acutatum, 90.1 % of C. fragariae, 95.4% of C. gloeosporoides at
48 h, and showed promising antifungal selectivity against P. viticola (79.9 %) and P. obscurans
(-21.7%) at 120 h. (Figure 3.9-3.13). In Figure 3.9 and 10, compound 20 exhibited moderate
antifungal activities against C. acutatum and C. fragariae compared to the standard fungicide
azoxystrobin, which only caused 40.5% and 58.9% respectively. These data suggested that
compound 20 could be considered as a novel natural product lead for the development of
fungicidal agent against strawberry pathogens. Compound 21 showed low antifungal activity and
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at 30 µM caused 50.4% growth inhibition of C. fragariae, 60.2% of C. gloeosporoides at 48 h
(Figure 3.10 and 3.11). Compound 21 showed promising antifungal selectivity between P.
viticola (80.3 %) and P. obscurans (22.5%) at 120 h (Figure 3.12 and 3.13). Compound 26 and
28 showed no antifungal activities against three Colletotrichum species, but showed good
selectivity over P. viticola (53.9% and 79.4%) and P. obscurans (25.6% and 10.3%) (Figure 3.12
and 3.13). Due to these properties, compounds 20, 21, 33 and 35 could be further evaluated as
fungicidal leads for pest and disease control.
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Figure 3.10 Mean fungal growth inhibition (%) of Colletotrichum acutatum after exposure to 12,
13, 14 and 16 using a dose-response format at 48 h. Abreviations: Cap: Captan; Azo:
Azoxystrobin; Ben: Benomyl. (12: compound 20; 13: compound 21; 14: compound 33; 16:
compound 35).
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Figure 3.11 Mean fungal growth inhibition (%) of Colletotrichum fragariae after exposure to 12,
13, 14 and 16 using a dose-response format at 48 h.
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Figure 3.12 Mean fungal growth inhibition (%) of Colletotrichum gloeosporoides after exposure
to 12, 13, 14 and 16 using a dose-response format at 48 h.
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Figure 3.13 Mean fungal growth inhibition (%) of Phomopsis viticola after exposure to 12, 13,
14 and 16 using a dose-response format at 120 h.
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Figure 3.14 Mean fungal growth inhibition (%) of Phomopsis obscurans after exposure to 12, 13,
14 and 16 using a dose-response format at 120 h.
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After overall study of the relationship between the structures and antifungal activities of the
pure isolates at 30 µM, we found several essential positions that might be responsible for their
antifungal activities (Table 3.1). Comparing the structures between compound 20 and 21, the
absolute configuration of C-6’ affects antifungal activity. R configuration of C-6’ in 21 greatly
decreased antifungal activity against Colletotrichum species, but slightly increased the antifungal
activities against Phomopsis species. Comparing the structures between 21 and 33, introduction
of one hydroxyl group at C-5’ position caused complete loss of antifungal activity against
Colletotrichum species and decreased the selectivity against Phomopsis species, which indicated
the importance of openness of 5’ position to keep it active. By comparing the structures between
21 and 34, the replacement of hydroxyl group with methoxy group at C-8 caused broad loss of
antifungal activities against all the test fungi, which indicated this position might be the active
site where hydrogen bonds were formed to enhance the interaction between the enzyme and
agent. Comparing compound 33 and 35, the replacement of hydrogen at C-6 and C-5’with acetyl
groups greatly increased the selectivity against Phomopsis species.
Therefore, S configuration of C-6’, openness of C-5’, hydroxyl group at C-8, and
introduction of functional groups at C-6 are several remarkable observations we obtained from
the antifungal SAR study. This might provide us some useful information for further SAR study.
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Table 3.1 Overall Fungal Growth Inhibition of Compounds 20, 21 and 26-30 Against Plant
Pathogens at 30 µM.
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3.3.2.2 Opioid &cannabinoid receptor binding affinity
The crude extracts, fractions and pure compounds isolated from this species have been
submitted for testing to determine their affinity for opioid receptors (subtype δ, κ and µ) and
cannabinoid receptors (subtype CB1 and CB2). The result showed that only the crude extracts
possessed modest opioid effect (δ, 70.11; κ, 65.67; µ, 56.58). The binding affinity was lost in the
sub-factions and pure compounds of C. cladosporioides (Table 3.2). This indicated that the
combination of the active compounds in the crude extracts contributed to the affinity of opioid
receptors other than single compound. Synergism refers that two or more agents, when used
together, produce an effect greater than one single agent. It is very common phenomenon in
fungal extracts in which the active compounds interact within themselves to synergize the
therapeutic effects 191.
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Table 3.2 Binding Affinity Assay of the Cladosporium cladosporioides for Human Opioid
Receptors and Cannabinoid Receptors.

Species

Opioid Receptors (%)

Fractions

Cannabinoid
Receptors (%)

(10 µg/mL)
δ

κ

µ

CB1

CB2

70.11

65.67

56.58

21.6

20.5

-10.95

-27.96

36.3

8.3

-43.54

-12.89

0.9

10.0

27.2

-24.44

-37.72

-16.1

4.8

25%MeOH in 27.4

-14.57

-41.96

26.4

5.5

17.1

3.9

Cladosporium

Crude extracts

cladosporioides

25% Hexane in 53.7
EtOAc
50% Hexane in 36.5
EtOAc
EtOAc
EtOAc
MeOH

37.2

-20.49

-62.40

Cladosporin

-39.7

-24.1

42.3

-0.2

-18.9

-6.2

Naloxone (10 µM)

101.3

103.8

99.7

-

-

CP 55,940 (10 µM)

-

-

-

99.4

101.0

(10 µM)
5’Hydroxyaspere
ntin
(10 µM)

Note: For crude extracts and their fractions, the concentration is 10 µg / mL; for pure isolates, 10
µM was used.

3.3.2.3 In vitro antimicrobial activities of cladosporin and 5’-hydroxyasperentin
Since we have a good quantity of cladosporin (5.038 g) and 5’-hydroxyasperentin (117
mg) (Figure 3.9) (the quality of other pure compounds is less than 1 mg and not enough for
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further studies), these two compounds were submitted for their antibacterial and antifungal
(against human pathogens) activities. The antibacterial activities were tested against
Staphylococcus aureus, methicillin-resistant S. aureus (MRS), Escherichia coli, Pseudomonas
aeruginosa, and Mycobacterium intracellulare. Ciprofloxacin was used as positive control for
antibacterial activity.

The antifungal activities were evaluated against a panel of pathogenic fungi including
Candida albicans, C. glabrata, C. krusei, Aspergillus fumigatus and Cryptococcus neoformans
associated with opportunistic infections. Amphotericin B was included as a standard antifungal
drug for comparison. Cladosporin exhibited antifungal activity against Cryptococcus neoformans

with IC50 value of 17.72 µg/mL but no antibacterial activity against test organisms (if compounds
are not active at the highest test concentration of 20 µg/mL, we considered it to be inactive). 5’hydroxyasperentin did not show any antibacterial activity or antifungal activity against the ten
species. This indicated that substituents at 5’-position might lead to the loss of antifungal activity.
Furthermore, the number of double bonds in the side chain of the structure is normally crucial for
maintaining both antibacterial and antifungal activity. Both compounds lack of long side chain
with double bonds, which might be the reason for their weak or inactive properties.

3.3.2.4 Herbicidal activity of cladosporin
Cladosporin was also tested for its potential herbicidal activity. Three different
concentrations (10, 100 and 1000 µM) were used. Ranking of plant growth was subjective. A
ranking of 0 indicated no apparent inhibition (sample well plants looked identical to the Control
+ Solvent well plants). A ranking of 5 indicated no growth or complete inhibition. A ranking of
five was given only if no seeds germinated. From Table 3.3, Cladosporin showed moderate to
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high monocot herbicide activity against Agrostis, but no effect against dicots herbicidal activity
against Lettuce. Monocots (or monocotyledons) normally have a single embryonic seed leaf,
leaves with parallel veins, and flowers with parts in threes, while dicots (or dicotyledon) have
two embryonic seed leaves and leaves with netlike veins.

Table 3.3 Herbicidal Activity of Cladosporin
Compound

Concentration Solvent

Day

Cladosporin
Cladosporin
Cladosporin

10 µM
100 µM
1000 µM

7
7
7

(Ranking based on scale of 0 to 5.

10% acetone
10% acetone
10% acetone

Ranking
Lettuce
Agrostis
0
0
0
1
0
4

0=no effect; 5=no growth)

3.3.3 Experimental Sections

3.3.3.1 General experimental procedures
All melting points were obtained on a Thomas Hoover Uni-melt Capillary Melting Point
Apparatus and are uncorrected. All IR spectra were generated neat on an ATI Mattson FT-IR
using NaCl plates. Optical rotations were recorded using a Rudolph Research Analytical Autopol
V polarimeter. UV was respectively obtained using a Perkin-Elmer Lambda 3B UV/vis
spectrophotomer. 1H and

13

C NMR spectra were obtained on Bruker model AMX 500 NMR

spectrometers with standard pulse sequences, operating at 500 MHz in 1H and 125 MHz in 13C.
The chemical shift values were reported in parts per million units (ppm) from trimethylsilane
(TMS) using known solvent chemical shifts. Coupling constants were recorded in Hertz (Hz).
Standard pulse sequences were used for COSY, HMQC, HMBC, TOCSY, NOESY and DEPT.
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High-resolution mass spectra (HRMS) were measured on a Micromass Q-Tof Micro mass
spectrometer with a lock spray source. Column chromatography was carried out on silicagel (70230 mesh, Merck) and Sephadex LH-20 (Mitsubishi Kagaku, Tokyo, Japan). TLC (silica gel 60
F254) was used to monitor fractions from column chromatography. Preparative TLC was carried
out on silica gel 60 PF 254+366 plates (20 × 20 cm, 1 mm thick). Visualization of the TLC plates
was achieved with a UV lamp (λ=254 and 365 nm) and anisaldehyde/acid spray reagent (MeOH:
acetic acid: anisaldehyde: sulfuric acid, 85:9:1:5). HPLC analyses were performed on a Waters
LC Module I equipped with a UV detector 486 utilizaing the Millenium 32 Chromatography
Manager software (Waters). An ODS column (Phenomenex Luna C18, 10 × 250 mm, 5 µm) was
used. All HPLC solvents were HPLC grade, filtered through appropriate membranes (water
through 0.45 µm and organic solvents through 0.22 µm filters) and sparged prior to and during
analysis with nitrogen at a flow rate of 50 mL/min.

3.3.3.2 Fungal material
The fungus was collected in Tifton, Georgia, in 1978, lyophilized, and stored at -20 °C.
The fungus was plated out on potato-dextrose agar, which was maintained at 24°C until discrete
fungal colonies appeared. Then 50 mL of potato-dextrose broth was inoculated with the fungus
and incubated for two weeks in stationary phase at 24 °C. The fungus was subsequently seeded
onto a shredded wheat medium consisting of100 g of shredded wheat and 200 mL of Difco
mycological broth (pH 4.8) (40 g of yeast extract, 400 g of sucrose and 100 g of mycological
broth in 2 L DDI H2O) in a 2.0 L Fernbach flask (15 flasks were used) followed by incubation
for 22 days at 24 °C 188.
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Figure 3.15 Bioassay-guided isolation of bioactive compounds from C. cladosporioides using
bioautography.

3.3.3.3 Extraction and isolation
Following incubation, 300 mL of acetone was added to each flask, and the fungus and the
substrate were homogenized. The suspension was filtered and the filtrate was concentrated under
vacuum at 40 °C to yield water fraction. The water extraction was then extracted with EtOAc
(500 mL × 3). The combined EtOAc extracts were dried over anhydrous Na2SO4 and
concentrated under a vacuum. The EtOAc extract (21 g) was chromatographed on silica gel 60,
70-230 mesh (400 g), with fractions stepwise eluted with hexanes, ethyl acetate and methanol,
yielding Fractions A-G. Bioautography-guided bioassay showed fraction C, D and E exhibited
antifungal activities and were selected for further bioassay-guided isolation (Figure 3.16).
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C

D

E

Figure 3.16 Antifungal activities with very clear inhibitory zones of fractions C, D and E from C.
cladosporioides crude extracts.

Fraction C was purified by HPLC on RP-18 using a MeOH-H2O gradient to afford four
compounds, cladosporin (20) (5.038 g), isocladosporin (21) (8.3 mg), palmitic acid (29) (10 mg)
and linoleic acid (30) (8 mg). Fraction D was separated on Sephadex LH-20 CC eluting with
DCM-MeOH (1:1) to afford 128 fractions. Sub-fractions 72-128 were combined to afford 5’hydroxyasperentin (26) (117 mg). Sub-fractions 31-71 were combined and were separated by
Biotage Isolera 1-EV system using a CHCl3/MeOH gradient to afford cladosporin-8-methyl ether
(27) (3 mg) (Figure 3.15). 5’-hydroxyasperentin (50 mg) reacted with 2 mL acetic anhydride and
2 mL pyridine (catalyst) for 24 hours to generate three less polar compounds. These three
compounds were purified by preparative TLC (developed with petroleum: EtOAc 1:1) and dried
under nitrogen to give one pure compound, 6, 5’-diacetyl cladosporin (28, 4.5 mg). The electrons
transfer in this reaction was shown as below:
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*Pyrindine has a lone pair of electrons on nitrogen which cannot be delocalized around the
ring, making nitrogen a common nucleophile and often used in acetylation reactions.

Cladosporin (20): white solid; [α]20D = -14.0(c = 1.0, EtOH); mp 175−177 °C; 1H NMR (400
MHz, CDCl3) δ 10.99 (d, J= 1.6 Hz, 1H), 8.46 (m, 1H), 6.29 (d, J= 2.0 Hz, 1H), 6.16 (d, J=
1.6Hz, 1H), 4.71−4.66 (m, 1H), 4.13−4.10 (m, 1H), 3.97 (br s, 1H),2.88−2.75 (m, 2H),
2.02−1.95 (m, 1H), 1.84−1.78 (m, 1H), 1.68− 1.53 (m, 4H), 1.37−1.32 (m, 2H), 1.20 (d, J = 6.4
Hz, 3H);

13

C NMR(100 MHz, CDCl3) δ 170.1, 164.1, 163.7, 141.6, 106.9, 101.8, 101.0,76.3,

67.8, 66.6, 38.8, 33.4, 30.9, 30.6, 19.0, 18.0; HRESIMS calcdfor C16H21O5 [M + H]+ 293.1384,
found 293.1389.
Isocladosporin (21): a white solid; [α]20D = −5.0 (c = 1.0, CHCl3); mp 158−159°C; 1H NMR (400
MHz, CDCl3): δ 11.07 (d, J = 2.0 Hz, 1H), 7.83(m, 1H), 6.34 (d, J = 2.0 Hz, 1H), 6.17 (s, 1H),
4.83−4.78 (m, 1H),3.72−3.66 (m, 1H), 3.49−3.45 (m, 1H), 2.84−2.71 (m, 2H), 1.92−1.71 (m,
3H), 1.60−1.50 (m, 3H), 1.27−1.20 (m, 2H), 1.15 (d, J = 6.4Hz, 3H);

13

C NMR (100 MHz,

CDCl3) δ 170.3, 164.2, 163.3, 141.9, 106.8, 101.9, 101.3, 76.0, 74.1, 73.2, 41.7, 33.6, 33.1, 31.6,
23.4, 22.0;HRESIMS calcd for C16H21O5 [M + H]+ 293.1384, found 293.1394.

3.3.3.4 X-ray crystallographic study of cladosporin
A single-crystal X-ray diffraction study was conducted on compound 20. C16H20O5,

	
  

71

MW=292.3, pale yellow needles were obtained with the slow evaporation of a solution in ethyl
acetate. A single crystal, approximate dimensions 0.45 × 0.36 × 0.20 mm, was used for data
collection on a Bruker Smart Apex II system, using Cu KR radiation with a graphite
monochromator, fine-focus sealed tube. The crystal was kept at 100 K under a stream of cooled
nitrogen gas from a KRYO-FLEX low-temperature device. Cell dimensions are α = 862.1 (2) Å,
b = 6.8656 (3), c = 1427.8 (3), ß = 1168.6 (3) pm, V = 1438.4 (6) 106 pm3. Data collection,
indexing, and initial cell refinements were all carried out using APEX II software. All nonhydrogen atoms were visible in the difference electron density maps and refined with riding
model at idealized positions. Anisotropic displacement parameters were included in the
refinement for all non-hydrogen atoms. Frame integration and final cell refinements were done
using SAINT software; 2064 reflexions 4.5 < 2θ < 52°, -2 < h <10, 0 < k < 14, 0 < l < 17, 2002
independent intensities (Rint = 0.015), no absorption correction. Refinement converged at R1 (I
> 2σ (I))=0.038, wR2 (all data) = 0.087, S = 1.049, max. (δ/σ) = 0.001, min/max height in final
ΔF map -0.16/0.15 e Å-3. Structure solution, refinement, graphics, and generation of publication
materials were performed using SHELXTL, V6.12 software. Hydrogen atoms were placed in
their expected chemical positions using the HFIX command and were included in the final cycles
of least-squares refinement, with isotropic Uij’s related to the atoms ridden upon (Figure 3.17).
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Figure 3.17 Crystal structure of cladosporin (20) from C. cladosporioides.

3.3.3.5 HPLC spectrum of cladosporin and isocladosporin
A partial of ethyl acetate fraction was purified by HPLC on RP-18 using gradient elution
from H2O/MeOH (starting with 80:20 for 10 min, and then MeOH increased to 100% within 30
min; 100% MeOH for 10 min) with the flow of 8 mL/min. The big two peaks refer to
cladosporin and isocladosporin with retention time of 43 min and 44 min, respectively (Figure
3.18).

Figure 3.18 HPLC spectrum of cladosporin (20, left peak) and isocladosporin (21, right peak).
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3.3.3.6 Opioid and cannabinoid binding assay
Cell Culture. CHO-K1 cells (ATCC) were stably transfected via electroporation with full
length human recombinant cDNA for cannabinoid receptor subtypes 1 and 2 (obtained from
Origene). These cells were maintained at 37oC and 5% CO2 in a Dulbecco’s Modified Eagles’s
medium (DMEM) nutrient mixture F-12 HAM supplemented with 2 mM L-glutamine, 10% fetal
bovine serum, 0.5% penicillin–streptomycin, and G418 (600 mg/mL). CHO-K1 cells stably
transfected with opioid receptor subtype δ, κ and µ were a generous gift from Roth labs
(University of North Carolina at Chapel Hill, Chapel Hill, N.C., U.S.A.). These cells were
maintained at 37oC and 5% CO2 in a DMEM nutrient mixture supplemented with 2mM Lglutamine, 10% fetal bovine serum, 0.5% penicillin–streptomycin, and either G418 (600 mg/mL)
or hygromycin B (300 mg/mL). Membranes were prepared by scraping the cells in a 50 mM
Tris-HCl buffer, homogenized via sonication and centrifuged for 40 minutes at 13650 rpm at 4oC.
These were kept at -80oC until used for binding assays. Protein concentration was found via BioRad Protein Assay 192.

Radio-ligand Binding for Cannabinoid and Opioid Receptor Subtypes. Cannabinoid binding
took place under the following conditions: 10 µM of each compound was incubated with 0.6 nM
[3H] CP 55,940 and 10 µg CB1 or CB2 membrane for 90 minutes in a salinized 96-well plate.
The reaction was terminated via rapid vacuum filtration through GF/C filters presoaked with
0.3% BSA using a Perkin Elmer 96-well Unifilter (Perkin Elmer Life Sciences Inc., Boston,
Mass. U.S.A.) followed by 10 washes of 50 mM Tris-HCl. Plates were read using a Perkin Elmer
Topcount (Perkin Elmer Life Sciences Inc., Boston, Mass. U.S.A.). Total binding was defined as
binding in the presence of 0.1% DMSO. Nonspecific binding was defined as binding observed
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in the presence of 10 µM CP55, 940. Specific binding was the difference between total and
nonspecific binding. Percent binding was found with the following formula: 100-(Binding of
compound- nonspecific binding)*100/Specific Binding. Opioid binding took place under the
following conditions: 10 µM of each compound was incubated with [3H]-DAMGO (µ), [3H]-U69, 593 (κ), or [3H]-Enkephlin (δ) for 60 minutes in a 96-well plate. Tritium and membrane
concentration for each cell line was determined by saturation experiments performed after each
batch of membrane was scraped. The reaction was terminated via rapid vacuum filtration through
GF/B filters presoaked with 0.3% BSA using a Perkin Elmer 96-well Unifilter followed by 10
washes of 50 mM Tris-HCl. Total binding was defined as binding in the presence of 0.1%
DMSO. Nonspecific binding was defined as binding observed in the presence of 10 µM
DAMGO (µ), nor-Binaltorphimine (κ), or DPDPE (δ). Specific binding was the difference
between total and nonspecific binding. Percent binding was found with the following formula:
100-(Binding of compound- nonspecific binding)*100/Specific Binding. Ki and IC50 values were
calculated using Graph-Pad Prism 5.

3.3.3.7 In vitro antimicrobial assay
All organisms used for the biological evaluation of the metabolites from Eurotium repens
were obtained from the American Type Culture Collection (Manassas, VA) and include the fungi
Candida albicans ATCC 90028, Candida glabrata ATCC 90030, Candida krusei ATCC 6258,
Cryptococcus neoformans ATCC 90113, and Aspergillus fumigatus ATCC 204305 and the
bacteria Staphylococcus aureus ATCC 29213, methicillin-resistant S. aureus ATCC 33591
(MRS), Escherichia coli ATCC 35218, Pseudomonas aeruginosa ATCC 27853, and
Mycobacterium intracellulare ATCC 23068. Susceptibility testing was performed using a
modified version of the CLSI (formerly NCCLS) methods 193. M. intracellulare was tested using
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a modified method194. Samples were serially diluted in 20% DMSO/saline and transferred in
duplicate to 96-well flat bottom microplates. Microbial inocula were prepared by correcting the
OD630 of microbe suspensions in incubation broth to afford final target inocula. Ciprofloxacin
(ICN Biomedicals, Ohio) for bacteria and amphotericin B (ICN Biomedicals, Ohio) for fungi are
included as positive controls in each assay. All organisms were read at either 630 nm using the
Biotek Powerwave XS plate reader (Bio-Tek Instruments, Vermont) or 544ex/590em, (M.
intracellulare, A. fumigatus) using the Polarstar Galaxy Plate Reader (BMG LabTechnologies,
Germany) prior to and after incubation. Percent growth was plotted versus test concentration to
afford the IC50.

3.3.3.8 Herbicidal activity of cladosporin
The lettuce used was Iceberg A Crisphead from Burpee Seeds. Agrostis seeds were
Penncross variety (Creeping Bentgrass species) obtained from Turf-Seed, Inc of Hubbard,
Oregon. For seed preparation, all seeds were surface sterilized prior to use in any bioassay by
mixing with a 5 to 10% Chlorox solution for approximately 10 minutes. Seeds were thorough
rinsed with deionized water (Millipore system) and air-dried in a sterile environment. All
bioassays were done in duplicate in sterile non-pyrogenic polystyrene 24-well cell culture plates
(CoStar 3524, Corning Incorporated). One filter paper disk (Whatman Grade 1, 1.5 cm) was
placed in each well to be used. The control wells contained 200 mL of Millipore water. The
control + solvent well contained 180 mL of water and 20 mL of the solvent. All sample wells
contained 180 mL of water and 20 mL of the appropriate dilution of the sample. Water was
always pipetted into the well before the sample or solvent. All plate preparation was done in a
sterile environment to lessen chances of any possible contamination. Figure 3.19 showed

	
  

76

cladosporin selectively inhibited the growth monot (agostis) and showed no activity against dicot
(lettuce) (Figure 3.19).

Figure 3.19 Herbicidal activity of cladosporin against monocot (Agrostis)

When prepping lettuce plates, five seeds were placed in each well. Lids were sealed with
Parafilm. The plates were incubated in a Percival Scientific CU-36L5 incubator under
continuous light conditions at 26°C and 120.1 umol s-1 m-2 average light intensity. Plates were
incubated for at least seven days. Ranking of plant growth was subjective. Ranking was based on
a scale of 0 to 5. A ranking of 0 indicated no apparent inhibition (sample well plants looked
identical to the Control + Solvent well plants). A ranking of 5 indicated no growth or complete
inhibition. A ranking of five was given only if no seeds germinated.
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3.4 IDENTIFICATION AND BIOLOGICAL STUDY OF THE FUNGUS MILOGRANTE
The fungus Milograntewas the second fungus chosen for further isolation study. In the
bioautography bioassay, it showed very good antifungal activity against three Colletotrichum
species (Figure 3.8)

3.4.1 Identification of Fungus Milogrante

3.4.1.1 Results
The fungus Milogrante is inoculated in malt extract agar (MEA) after 10 days at 25 ± 2°C,
under cool-white fluorescent lights (55 ± 5 µmol/m2/s) with a 12 h photoperiod, colonies with 23
mm of diameter, expanding, velvety, olivaceous green and reverse olivaceous black (Figure 3.20
a & b). The fungus shown conidiophores 50 µm long, 2-6 µm wide, without swellings, with
terminal and lateral ramifications, bearing branched conidial chains, pale olivaceous brown,
conidia ellipsoidal to limoni-form, smooth-walled, olivaceous brown, 1-celled, with dark scars
(Figure 3.20 c). In addition, the sequence of fungus Milogrante displayed 99% of identity with
different sequences of cultivable and non-cultivable fungi deposited in GenBank database.
However, according to Gaziset al. (2011) 195and Koet al. (2011) 196, sequencing of the ITS region
may fail to recognize some Ascomycota taxa and for this reason there are several erroneous
fungal sequences deposited in GenBank. To increase the taxonomy accuracy and avoid mistakes
on the phylogenetic inferences, the ITS1-5.8S-ITS2 nuclear ribosomal gene sequence of the
fungus Milogrante was compared with sequence of type species of Cladosporium
cladosporioides (Figure 3.20 d). In the phylogenetic analysis, the nucleotides difference among
the fungus Milogrante and the sequence of the type species Cladosporium cladosporioides CBS
144.35 (HM148012) was of the one nucleotide (0.17 %). Using physiological, morphological
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characteristics and molecular techniques, the fungus Milogrante was identified as Cladosporium
cladosporioides (Fres.) de Vries.

Figure 3.20 Taxonomic data of the fungus Milogrante. (a & b: Morphological verse and reverse
aspect of culture after 7 days on MEA at 7 days at 25 ± 2°; c: micromorphological structures
(conidiophores and conidia)).

Cladosporium cladosporioides [GU566222]
Uncultured fungus [FN397199]
Uncultured fungus [GU065631]
Uncultured organism [JN660485]
Uncultured fungus [GU721627]
Uncultured fungus [JF289125]
Cladosporium cladosporioides CBS 145.35 [HM148013]
Cladosporium sp. [HQ631003]
Fungal endophyte sp. [HM537019]
XAO
Cladosporium sp. [HQ717404]
Cladosporium cladosporioides [HQ832794]
Cladosporium sp. [GU214631]
Davidiella tassiana [FN868485]
Uncultured fungus [GU054204]
Uncultured Cladosporium [FN539065]
Trametes versicolor [AF042324]
0.1

!

Figure 3.20 d Phylogenetic analysis of the fungus and their nearest relatives. The tree was
constructed based on the rRNA gene sequences (ITS1-5.8S-ITS2) by using the maximum
composite likelihood model; the tree was rooted with Trametes versicolor [AF042324] as an
outgroup. Tsequence of type species is shown in gray box.
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3.4.1.2 Phylogenetic analysis
Genomic DNA from the fungus Milogranteas extracted with DNeasy Plant Mini Kit
(Qiagen Inc., Valencia, CA) and used as a template in PCR amplifications. The ITS1-5.8S-ITS2
genomic region (ITS) was amplified from genomic DNA using the forward primer ITS1 (5´TCCGTAGGTGAACCTGCGG-3´)

and

the

reverse

primer

ITS4

(5´-

TCCTCCGCTTATTGATATGC-3´) 197. PCR amplifications were carried out in 50 µL reaction
mixture containing 1x PCR reaction buffer, 0.2 mM dNTP mixture, 0.2 µM of each forward and
reverse primers, 1.5 mM MgSO4 and 2 U of Platinum Taq DNA Polymerase (Invitrogen, CA).
The PCR program consisted of one initial denaturation step at 94°C for 3 min followed by 40
cycles at 94°C for 30 sec, 50°C for 30 sec, 72°C for 1:30 min, with a final extension at 72°C for
7 min. PCR was performed in an M&J Research Gradient Cycler PTC-225. After amplification,
an aliquot was analyzed by electrophoresis on a 1% TAE agarose gel, visualized under UV light
and PCR products were compared to the molecular size standard 1kb plus DNA ladder
(Invitrogen, city CA). Successfully amplified PCR products were extracted using MinElute PCR
Purification Kit (Invitrogen, city CA) and sequenced on an automated DNA Sequencer (model
ABI 3730XL; Applied Biosystems, Foster City, CA). Consensus sequence data of the endophytic
fungus was submitted to the GenBank database under the number NRRL 5507.The sequence
obtained was submitted to phylogenetic inferences, which were estimated using MEGA Version
5.0

198

. The maximum composite likelihood model was used to estimate evolutionary distance

with bootstrap values calculated from 1,000 replicate runs. The sequence of the type fungal
species and some references sequences deposited in GenBank were added to phylogenetic
analysis accuracy. Information about the fungal taxonomic hierarchical levels follows the
databases MycoBank (www.mycobank.org) and Index Fungorum (www.indexfungorum.org).
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3.4.1.3 Physiological and morphological analysis
The physiological and morphological characteristics of the fungus Millogrante were
observed on 2% malt extract agar ((malt extract 2%, peptone 0.1%, glucose 1.5% and agar 2%
(MEA)). The colony diameter was measured on media, which was inoculated in three-point
cultures and incubated for 7 days at 25 ± 2°C under cool-white fluorescent lights (55 ± 5
µmol/m2/s) with a 12 h photoperiod to sporulation. A duplicate set of MEA plates was incubated
in the dark at 25°C to microscopic parameters determination using slide cultures mounted in
methyl blue in polyvinyl-lactophenol.

3.4.2 Biological Study of Isolate 2 of C. cladosporioides (Milogrante)
NMR-guided isolation showed that almost all the active constituents in isolate 2 are fatty
acids, which is totally different from that in isolate 1. Fatty acid refers to a carboxylic acid
bearing a long unbranched aliphatic chain. The long chain can be monounsaturated,
polyunsaturated, or saturated with even number of carbons in the majority of naturally occurring
fatty acids. Fatty acids play important roles in our daily life. As an important part of a healthy
diet, they keep skin healthy, prevent early aging and promote weight loss

199

. They also aid cell

membrane development, strength, and function, which is essential for organs and tissue. Some
polyunsaturated fatty acids are known to be major components of the human central nervous
system (CNS). For example, Docosahexaenoic acid (DHA) and arachidonic acid (AA) are major
components of the CNS, where they play a critical role in neural development. DHA has been
shown to be essential in the prevention of numerous diseases. Low levels of DHA may lead to
Alzheimer's disease. Arachidonic acid (AA) is another important fatty acid, which is a key
inflammatory intermediate 200, 201, 202.
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In recent years, more and more natural lipids have been identified as endogenous leads
for the central cannabinoid receptors which belong to family of GPCRs and are associated with
many processes including pain, craving, neurodegeneration, metabolic regulation, anxiety and
immune function

203, 204

. So discoveries in cannabinoid receptors have provided an exciting

future for cannabinoid receptor-based therapies to treat a variety of disorders in CNS

205

.

Linoleic acid is an omega-6 essential polyunsaturated fatty acid and its deficiency can result in
symptoms such as hair fall, dry hair, and poor wound healing 206. Palmitic acid is one of the most
common saturated fatty acids found in animals and plants and mainly used to produce soaps,
cosmetics, and release agents 207.

3.4.2.1 Opioid and cannabinoid receptor binding affinity
The EtOAc crude extract (36 g) of the isolate of C. cladosporioides (Milogrante) was
chromatographed on silica gel 60, 70-230 mesh (400 g), with fractions stepwise eluted with
hexanes, ethyl acetate and methanol, yielding seven fractions (fractions 1-7). The crude extracts
and their fractions were submitted for opioid and cannabinoid receptor testing. The result showed
that fractions 2 (Hex: EtOAc 1:1) showed promising activities against all three opioid receptors
(δ, 92.80; µ, 95.07; and κ, 91.98) and fraction 3 (100% EtOAc) and fraction 6 (100% MeOH)
showed modest activities against δ receptor. The crude extracts and fractions 1 (100% Hexanes),
fraction 4 (MeOH: EtOAc 25:75), fraction 5 (MeOH: EtOAc 50:50) and fraction 7 (MeOH: H2O
50:50) showed weak or no binding affinities for opioid receptors. All the fractions had no
CB1/CB2 affinities. And then, fraction 3 (3.14 g) was chromatographed on liquid silica column
to give 14 sub-fractions which were subsequently tested by opioid and cannabinoid receptor
assays. The result showed 3 sub-fractions (DCM/EtOAc 60/40 (δ, 78.4); DCM/EtOAc50/50 (δ,
70.84); DCM/EtOAc40/60 (κ, 59.82)) had affinity for δ or κ receptor (Table 3.4).
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Table 3.4 Binding Affinity Assay of the Fungus Migrante for Human Opioid Receptors and
Cannabinoid receptors.
!

Species

Fractions (10 !g/ml)

XWMigrante

Crude extracts
100% Hexanes
Hex:EtOAc (1:1)
EtOAc
MeOH:EtOAc
(25:75)
MeOH:EtOAc (1:1)
100% MeOH
MeOH: H2O
DCM:EtOAc (6:4)
DCM: EtOAc (1:1)
DCM:EtOAc (4:6)
Naloxone (10 !m)
CP 55,940 (10 !m)

Opioid
(%)
"
20.38
-2.71
92.80
53.96
47.90

Receptors Cannabinoid
(%)
#
µ
CB1
49.06 44.23 43.2
23.15 25.14 -24.20
91.98 95.07 -70.63
20.27 38.47 -52.83
6.58 22.14 -59.96

Receptors
CB2
8.7
-38.24
-25.87
-42.32
-17.36

33.85
57.16
39.67
78.4
70.84
89.15

4.41
7.30
13.78
59.82
98.65

35.75
47.45
33.30
99.42

-55.80
-67.04
-44.11
-

-16.95
1.60
6.71
-

-

-

-

105.75

100.19

3.4.2.2 Antifungal study
The crude extracts, fractions and sub-fractions from the isolate 2 of C. Cladosporioides
were tested for their antifungal activity against three Colletotrichum species using bioautography.
The crude extracts and fractions 6 (100% MeOH) and fraction 7 (MeOH: H2O 50:50) showed
very good inhibition zones against C. fragariae (Figure 3.22).
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CHCl3: MeOH 7:3

Fraction 6

Fraction 7

Figure 3.22 Bioautographic result of fraction 6 and fraction 7 against C. fragariae. Four µL of 20
mg/mL with 1 cm band size of fraction 6 and fraction 7 were applied at 1 cm measured from the
bottom edge of the TLC (10 × 10 cm) and developed with CHCl3: MeOH (7:3).

Fractions 6 were purified using gradient HPLC with acetonitrile and water. Two fractions
were obtained at 20.93 min and 21.77 min (Figure 3.23). They were tested to exhibit promising
antifungal activity against C. fragariae (Figure 3.24). NMR data showed that they all belonged
to fatty acids.
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Figure 3.23 HPLC spectrum of two fatty acids (20.93 min, 21.77 min) from fraction 6.

Figure 3.24 Bioautographyic result of two fractions from fraction 6.

After GC/MS analysis, these two fractions were determined as linoleic acid and palmitic
acid. The mixtures of these two acids with different ratios were tested for the binding affinity for
human opioid receptors (µ, δ, κ) (done by Dr. Mohamed Radwan and Amer Tarawneh). The
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result showed that the mixture of linoleic acid and palmitic acid with 1:1 ratio was the most
potent with an IC50 value of 7.65 µM. This led us to believe that active components of these two
acids are working synergistically to produce their effects. To our best knowledge, this is the first
time to report opioid binding activity of these two acids. Besides the great potency of linoleic
and palmitic acids, they offer greater safety in their application than the synthesized or semisynthesiezed drugs. So these lipids need to be further exploited.
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CHAPTER 4 DEVELOPMENT OF A MINATURISED 24-WELL STRAWBERRY LEAF
DISK BIOASSAY FOREVALUATION OF NATURAL FUNGICIDES

4.1 INTRODUCTION
Effective disease control strategies for crop plant pathogens rely on the use of fungicides.
Wedge et al. reported on new fungicide management strategies for control of strawberry fruit rot
diseases in the Gulf state region and the need for efficacious fungicides to provide growers with
more options for controlling diseases

208

. Disadvantages of the use of these chemical controls

include the development of resistant fungal strains as well as potential environmental and
mammalian toxicities. Resistance of many plant pathogens to commonly used commercial
fungicides is becoming a serious problem and has limited the number of effective disease control
agents. For example, numerous isolates of Colletotrichum spp. developed benomyl insensitivity
(only showed 40%-60% fungus growth inhibition) after several years of use to protect strawberry
and other fruit crops

209

. Colletotrichum species often cause typical symptoms of anthracnose, a

disease characterized by sunken necrotic lesions usually bounded by a red margin

210

. As we

mentioned before, anthracnose diseases of strawberry (Fragaria × ananassa Duch) are serious
problems for fruit and plant production in many areas of the world

211

. The pathogens,

Colletotrichum fragariae A. N. Brooks, C. gloeosporioides (Penz.) Penz., and C. fragariae CF 75, can occur singly or in combination to infect flowers, fruit, leaves, petioles, stolons, and
crowns 212.
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In the continued fungicide discovery, we are focused on natural products derived from plants
and fungal organisms with emphasis on compounds with fungicidal activity213. Natural
antifungal agents are generally broad-spectrum compounds with low mammalian and
environmental toxicity and 3-dimensional structures that synthetic compounds may lack. Along
with discovery of new molecules with novel motion of action and our interest in antimicrobial
agents from higher plants and fungi

17

, a novel miniaturized bioassay for evaluating small

amounts of available compounds is also needed 214.

Development of new plant protectants with a lipophilic nature is limited by the lack of
suitable bioassays to properly evaluate these compounds. While the lipophilic nature of
phytochemicals allows them to embed themselves into the leaf waxes and persist through rainfall,
hence making them potentially useful agrochemicals, this characteristic also makes them very
difficult to evaluate in many aqueous bioassays. Examples include essential oils and many
marine extracts, which are hydrophobic and insoluble in most aqueous-based antimicrobial disc
diffusion and micro-dilution broth bioassays. Direct bioautography on silica gel is our preferred
primary screening bioassay and often the best assay for evaluating lipophilic compounds as
fungicides for agricultural use, because this assay more closely mimics a leaf surface. Classical
leaf bioassays, used to test fungicide efficacy at concentrations between 625 and 2500 ppm, may
use 75-100 mg of an experimental compound that is often difficult to obtain. Therefore, the need
for a novel miniaturized leaf disk bioassay that utilizes small sample sizes, has high throughput
capability, and replicates the real leaf surface is of utmost importance to natural product
fungicide discovery.

This study presents information about developing of a new 24-well

detached leaf bioassay for evaluation of natural fungicides.
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4.2 RESULTS AND DISCUSSION

4.2.1 Salt Solutions For 24-well Leaf Disk Assay
Leaf color index of 2.67 obtained after inspecting 7-day-old leaf disks indicated that half
strength Hoaglands No. 2 basal salt media (PhytoTechnology Laboratories) provided excised leaf
discs with the best physiological support (Table 4.1). Murashige and Skoog basal salts (SigmaAldrich) demonstrated the lowest color index of 1.83. While 2-N-morpholino ethane sulfonic
acid (MES, Sigma-Aldrich) and water (control) had a color index of 2.42 and 2.83 respectively.
However, MES and water did not gel sufficiently to provide adequate physical support to keep
leaf disks afloat for subsequent inoculation with the conidial solutions. Typical working
concentrations for Phytagel™ are 1.5-2.5 g/L in plant tissue culture media and up to 10 g/L in
microbiological media. Phytagel™ requires the presence of cations (especially divalent) for
gelling to occur. Concentrations of calcium and magnesium contained in most plant tissue
culture media are typically sufficient for gelation. Low-salt media formulations, especially those
used in microbiological applications may require supplementation with additional calcium or
magnesium salts (e.g., CaCl2 or MgSO4) or higher concentrations of Phytagel. Therefore we
chose ½ strength Hoaglands No. 2 basal salt media containing 1% Phytogel as the best medium
to conduct all subsequent 24-well leaf disk studies.
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Table 4.1 Half strength Hoagland’s No. 2, 2-N-morpholino Ethanesulfonic Acid (MES),
Murashige and Skoog Basal Salt Mixture (M&S) and Water (control) Were Evaluated for Their
Ability to Sustain Excised Leaf Discs for 7-10 days.
Salt Solution

Leaf Color Value (1-3)

Standard Error

H2 O

2.83 a

0.11

½ Hoagland’s

2.67 a

0.22

M&S

1.83 ab

0.30

MES

2.42 b

0.19

Mean leaf color index on a scale from 1-3 (1 = light green, 2 = medium green, 3 = dark
green) was used to describe leaf chlorophyll content. Means followed by the same letter are
not significant at p<0.05.

4.2.2 Pathogen Type, Surfactant, and Inoculum Volume
Colletotrichum fragariae (CF75), C. fragariae (CF63), and C. gloeosporioides (CG162)
were each evaluated for their ability to produce disease lesions under in vitro conditions at three
levels of Tween 20 (0.3 %, 0.5 %, and 0.7%). Mean necrosis indicated that Colletotrichum
fragariae (CF75) and C. gloeosporioides (CG162) produced the highest number of lesions under
in vitro conditions and C. fragariae (CF63) produced the lowest number of lesions (Table 4.2).
The best treatment combination was C. fragariae (CF75) where inoculum amended with 0.5%
and 0.7% Tween 20 produced 16.72 and 15.53 % necrosis of the leaf disks respectively. C.
gloeosporioides (CG162) showed no significant differences in leaf lesions between the three
Tween 20 concentrations. Lesion development (necrosis) indicated that there was no difference
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between 10 or 20 µL inoculum volumes for any of the three Colletotrichum spore suspensions
when applied to the leaf disk disks.

Table 4.2 Percent mean necrosis was used to evaluate the ability of Colletotrichum fragariae
(CF75), C. fragariae (CF63), and C. gloeosporioides (CG162) and three concentrations of
Tween 20 (0.3 %, 0.5 %, and 0.7%) in the inoculum solution to produce disease lesions on 15
mm leaf disks.
Fungal isolate &% Tween 20

% Mean Necrosis

Standard Error

CF63

0.3

7.34 cde

2.53

CF63

0.5

4.84 efg

1.12

CF63

0.7

5.78 def

2.05

CF75

0.3

10.78 bcd

2.13

CF75

0.5

16.72 a

0.93

CF75

0.7

15.53 ab

8.52

Cg162

0.3

12.47 abc

3.27

Cg162

0.5

11.58 abc

2.02

Cg162

0.7

12.00 abc

3.20

H2 O

0.3

0.56 fg

0.00

H2 O

0.5

0.14 g

0.00

H2 O

0.7

0.00 g

0.00

Means followed by the same letter are not significant at p<0.05.
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4.2.3 Phytotoxicity
Phytotoxicity evaluations were made visually at 12 hrs after treatment of the fungicidal
solution or solvent control and prior to inoculation (Figure 1).

Origanum onites essential oil

above 1250 ppm demonstrated a 4+ phytotoxicity ranking and A. sinensis essential oil
demonstrated 1+ phytoxicity ranking at 2500 ppm. Percent healthy tissue, percent leaf necrosis
and percent phytotoxicity of the leaf disk are presented in Table 4.3. The commercial fungicide
azoxystrobin at 625 ppm had the greatest level of disease control efficacy at 99% healthy tissue.
Even at 2500 ppm, azoxystrobin showed the lowest level of phytotoxicity (0.45%). Both O.
onitesand and A. sinensis essential oils were phytotoxic at higher doses (Figure 4.1 and 4.2).
Color analysis of Plate 1b (Figure 4.2) showed healthy area in green, diseased area in black and
phytotoxicity in gray. Origanum onites essential oil was more phytotoxic to strawberry leaves
than was A. sinensis essential oil. Angelica sinensis essential oil was a more effective antifungal
agent against all three Colletotrichum species.
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Table 4.3 Percent Healthy Tissue, % Leaf Necrosis, and % Phytotoxicity as Determined at Five
Days After Inoculation by a Lemnatec Lemna HTS and SAW Scanalyzer Analyzing Software.
Essential
Azoxystrobin

oil

of Essential

oil

of

Origaniumonites

Angelica sinensis

625

1250

2500

625

1250

2500

625

1250

2500

ppm

ppm

ppm

ppm

ppm

ppm

ppm

ppm

ppm

Control

% Healthy Tissue
CF75

99.29 98.93 99.16 65.03 9.79

16.43 92.59 79.65 36.73 86.18

CF63

99.55 99.51 99.64 96.17 7.32

20.94 96.02 72.20 16.18 92.22

Cg162

99.65 99.21 99.80 98.66 33.72 17.42 98.53 97.33 27.64 94.27

% Leaf Necrosis
CF75

0.40

0.55

0.39

25.81 29.78 1.02

6.49

8.78

9.59

13.01

CF63

0.13

0.23

0.03

3.39

17.17 0.33

2.89

7.58

0.09

6.85

Cg162

0.04

0.40

0.09

1.13

15.97 7.19

1.05

1.42

0.91

4.85

% Phytotoxicity

	
  

CF75

0.31

0.52

0.45

9.16

60.44 82.55 0.92

11.57 53.67 0.80

CF63

0.31

0.26

0.33

0.44

75.51 78.72 1.09

20.21 83.73 0.93

Cg162

0.31

0.39

0.11

0.21

50.31 75.39 0.42

1.25

94

71.44 0.88

625

Plate 1

1250

1250

2500

2500

A

Azoxystrobin

B

Origanum onites

C

Angelica sinensis

D

20% Ethanol control
625

Plate 2

625

625

1250

1250

2500

2500

A

Azoxystrobin

B

Origanum onites

C

Angelica sinensis

D

20% Ethanol control

Figure 4.1 Phytotoxicity produced by Organium onites and Angelica sinensis. 15-mm excised leaf
disks from anthracnose susceptible strawberry cultivar ‘Chandler’ demonstrate easy to visualize 4+
phytotoxicity of Organium onites essential oil above 1250 ppm. Angelica sinensis essential oil
demonstrated 1+ phytoxicity at 2500 ppm. Plate 1 and plates 2 are duplicate treatments showing
subtle variation in phytotoxicity bleaching between replicate plates.
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625 625

Plate 1a

1250

2500

2500

Azoxystrobin

A
B

Origanum onites

C

Angelica sinensis

D

20% Ethanol control
625

Plate 1b

1250

625

1250

1250

2500

2500

A

Azoxystrobin

B

Origanum onites

C

Angelica sinensis

D

20% Ethanol control

Figure 4.2 Photographic image of the phytotoxicity produced by Organium onites and Angelica
sinensis. Plate 1a is a photographic image of 15-mm excised leaf disks from anthracnose
susceptible strawberry cultivar ‘Chandler’ following 3-5 second dip in fungicide test solutions
in a dose-response format and inoculated 12 hrs later with CF75. Plate 1b is an image analysis
of Plate 1a using the LemnaTec and SAW Scanalyzer analyzing software showing healthy
tissue in green, diseased (necrotic) lesions in black, and bleached tissues (phytotoxicity) in
gray.
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4.3 EXPERIMENTAL

4.3.1 Plant Preparations
Plants of the anthracnose-susceptible cultivar Chandler were obtained in October 2007
from Shingleton Farms (Statonsburg, NC, USA), planted into 14 cm plastic azalea pots
containing Metromix 350 (BWI- Memphis, TN), and placed in the greenhouse without shade.
Plants were watered daily and Peter’s 20-20-20 nutritional solution (BWI- Memphis, TN) was
applied weekly. Plants with any signs of disease were rouged and removed from the greenhouse
daily.

4.3.2 Leaf Disc Preparation
The first or second fully expanded leaves were removed from stock strawberry plants and
transported directly to the laboratory so that the leaves were available for the bioassay in less
than 4 hours. Immediately after collection, the leaves were placed in a tray lined with moist
paper towels and the tray was closed to retain near 100% relative humidity (RH) and maintained
at ~12°C. Only leaves with no visible signs of injury or symptoms of disease were collected.
Whole leaves were disinfested by placement in a beaker with 2.5% Clorox for 3 min., then they
were rinsed 2-3 minutes in sterile distilled de-ionized water three times. Leaves with any signs of
bleaching were discarded. Strawberry leaf disks were then cut from the disinfested leaves using a
15-mm stainless steal cork borer and placed in moisture plate until they were placed in the 24well plate.
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4.3.3 24-well Leaf Disk Assay
Three commercial in vitro salt solutions were evaluated for their ability to maintain leaf
disks during the in vitro experiment: half strength Hoagland’s No. 2 (H, Phytotechnology
Laboratories, Shawnee Mission, KS), 2-N-morpholino ethanesulfonic acid (MES, Sigma M8250,
Sigma-Aldrich, St. Louis, MO), Murashige and Skoog basal salt mixture (MS, Sigma M5524).
Water (control) was also evaluated for its ability to sustain excised leaf discs for 7-10 days.
Stock solutions containing 1% Phytogel (Sigma P8169) were prepared as follows: Hoagland’s
No. 2 solution (0.815 g/L), MES (195.2 mg/L) containing 5 mL Gamborg's Vitamins (ThiamineHCl 5mg/L, Pyridoxine-HCl 0.5 mg/L, Nicotinic acid 0.5 mg/L, Myo-inositol 50mg/L), and MS
(2.2 g/L). All support solutions were adjusted to 6.5 pH using 0.1 N and 1.0 N NaOH. Excised
leaf disks were placed onto the 1500 µL of either respective solidified salts/medium contained in
each well of the 24-well plate. Plates were maintained in the sterile biological hood over night
prior to pathogen inoculation to allow time for the leaf disks to initiate wound healing and
acclimate to the in vitro system. The plates were sealed with paper-based tape and placed in the
incubator under (55±5 µmols·m-2·sec-1) (UFL-F17T8/741, Interlectric Corp., Warren, PA) with a
12 h photoperiod in a growth chamber at 25º C for one week. All samples were duplicated and
the experiments were repeated three times.

4.3.4 Pathogen and Inoculum Preparation
Three Colletotrichum isolates were evaluated for their ability to produce disease lesions
under the in vitro conditions of this study. Colletotrichum fragariae (CF75), C. fragariae (CF63),
and C. gloeosporioides (CG162) isolated from strawberry were evaluated for their ability to
produce anthracnose symptoms on excised strawberry leaf discs. Each Colletotrichum isolates
was grown on 1/2 strength potato dextrose agar (PDA) in 9-cm Petri dishes and incubated under
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Ushio Ultra 8 fluorescent lights (55±5 µmols·m-2·sec-1) at 25 °C as previously described (Abril
et al., 2008). Conidia were harvested from 7- to 10-day-old cultures, and the aqueous conidial
suspensions were filtered through sterile Miracloth (Calbiochem-Novabiochem Corp., La Jolla,
CA, USA) to remove hyphae. Conidial concentrations were determined photometrically from a
standard curve based on absorbance at 625 nm 215 and then stock suspensions were adjusted with
sterile water to a concentration of 106 conidia / mL. Conidial suspensions for inoculation were
then adjusted to a final concentration of 105 conidia/mL. Two inoculum volumes were evaluated
where the inoculum volume applied to each leaf disk was either 10 or 20 µL of any of the three
fungal spore suspensions. After leaf disk inoculation, the 24-well plate was sealed with paperbased tape again and placed in the incubator for 6 days. Three concentrations of Tween 20 were
also evaluated for their effects on promoting pathogen infection of the leaf disk. Tween 20
concentrations of 0.3%, 0.5%, and 0.7% were prepared in 100 mL sterile distilled water.

4.3.5 Disease Assessment and Phytotoxicity
Experimental compounds were evaluated in a dose-response format. Azoxystrobin that has
protective and some curative activity were used as standards for comparison. A 20% ethanol:
water solvent control is used in each study to solubilize lipophilic extracts. Angelica sinensis
roots were purchased as a plant material from Jincheng Lingyi Drugstore, Weinan City, Shaanxi
Province, China. Origanim onites essential oil was purchased from ALTES Company, Turkey.
Stock solutions containing 625, 1250, and 2500 ppm were prepared for azoxystrobin, Origanum
onites essential oil, Angelica sinensis essential oil and 20% ethanol solvent control in 50 mL
capped test tubes.
Strawberry leaf disks prepared as previously described were dipped in antifungal test
solutions for 3-5 seconds, excess solution was allowed to drain onto the edge of the test tube and
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then placed into the appropriate row and column of the 24-well plates. Plates were incubated
over night at room temperature and inoculated the next morning with either 20 uL of conidial
solution obtained from either C. fragariae (CF75), C. fragariae (CF63), or C. gloeosporioides
(CG162). Percent healthy tissue, percent leaf necrosis, and percent phytotoxicity were
determined at 5 days after inoculation by a LemnatecLemna HTS and SAW Scanalyzer
analyzing software (LemnaTec GmbH, Wurselen, Germany). The instrument was set up to
photograph (Sony DFW-SX900 camera) a 24-well plate containing the leaf disks using both top
lighting and bottom lighting (8 W fluorescent tubes) and optimized for disk clarity and color.
The software configurations were set to measure the area of each disk separately and classify the
colors detected within each leaf. Color classification was set to differentiate healthy tissue,
bleached tissue, and necrotic lesions on the leaf surface.

SAS (Statistical Analysis System, Cary, N.C.) was used to conduct analysis of variance and
mean separation tests on all three experiments. A completely randomized design was used for all
experiments. All factors were considered to be fixed effects, except for surfactant concentration
in the surfactant experiment. Fisher's protected LSD was used to separate means 216.
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Appendix: A
Protocol 1. Preparation of ½ Strength Potato Dextrose Agar (PDA)
Weigh/measure (using weighting boat on electronic balance 1/10000 gram)
1.

19.6 g

PDA Powder (Difco-Becton, Dickinson and Company)

2.

8g

Bacto Agar (Difco-Becton, Dickinson and Company)

3.

1000 mL DDI H2O (Ultra Pore Millipore System)

4.

Add to Flask, Heat, and Stir

5.

Stirs suspension until completely dissolve--Divide into 2 Erlenmeyer flasks (500 mL)-Cover the flask with aluminum foil & Autoclave tape – Autoclave at 121 oC for 45 min

Protocol 2. Preparation of ½ Strength Potato Dextrose Agar/Oatmeal (PO)
1. 24 g

PDA: OMA mixture

2. 8 g

Bacto Agar

3. 1000 mL

DDI

H2 O

4. Erlenmeyer flask /magnetic stirring bar on Heat/stirrer
5. Stirs suspension until completely dissolve--Move 1000 mL into 500 mL Erlenmeyer
flasks cover the flask with aluminum foil.
6. Autoclave

	
  

at

121

o

C

for

45

min

120

(don’t

forget

the

autoclave

tape).

Protocol 3. Preparation of Potato Dextrose Broth (PDB)
1. 12.5g

PDB Powder

2. 0.5g

Bacto Agar

3. 500mL

DDI H2O (Ultra Pore Millipore System)

4. 0.5mL

Tween 80 (add it after upper materials are dissolved)

5. Place on a stir plate and heat. While stirring and heating, pipette 0.5 mL of Tween 80 into
flask with magnetic stirring bar.
6. Stirs suspension until completely dissolve--Move 100mL into 250mL Erlenmeyer flasks
cover the flask with aluminum foil – Autoclave at 121 oC for 45 min (don’t forget the
autoclave tape).
7. Place 100 mL aliquots in the refrigerator.
8. Filter before use of spray (0.45 microns)

Protocol 4. Streaking Plates
1. Remove media plates from the refrigerator to be inoculated.
2. Allow plates to warm to room temperature.
3. Condensation on the plate lids, place the plates on the back of the hood with the lid
slightly opened to allow the condensation to evaporate.
4. Once there is no more condensation on the lid, close the plates.
5. Label the bottom plate of the petri dish.
i.e. ½ PDA C. fragariae fr. Stock 7-12-12 6-03-12 (today’s date)
6. Add 50 µL of the inoculums to each plate.
7. Streak the plate with a sterile inoculun loop. Change lops between each plate that is being
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streaked to reduce contamination.
8. Wrap the inoculated plate with 2 pieces of parafilm.
9. Place the inoculated plate in the appropriate growth chamber with the lid side facing up.

Protocol 5. Procedures of Fungus Harvest
1. Remove fungal isolates inoculated 7-10 days from Percival Growth Chamber @ 24 °C
(incubation period).
2. Test the contaminated situation of the fungi, discard the green ones, reserve the black
ones and discard the black parts.
3. Label sterile test tubes and the cuvettes according to fungal isolates before harvesting
(using the corresponding color codes).
4. Use different color label bands label each different fungal isolate to avoid mistakes.
5. Place sterile funnel into glass test tube using forceps.
6. Remove miracloth square from sterile wrap, pouch and place into funnel.
7. Place a fungal isolate (e.g. Ca Goff) plate onto turn table -----pipette 10 ml of sterile DDI
H2O into the plate ----using L cell spreader softly remove conidia from media.
8. Using Gilson 10ml Pipetman, pipette conidia suspension through Miracloth, seal test tube
with Parafilm square, and then place tube with suspension in ice bucket.
9. Prepare label microscope slide (size 25×75×1mm) and check for contamination using
Olympus BX60 (pipette 15 µL of conidia suspension onto slide /cover by using cover
glass).
10. Examine: prepare conidia suspension.
11. Collect spore suspension with pipette (10 mL) from media into sterile tube and remove
test tubes from ice bucket and place in refrigerator until over night for harvesting spore
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deposition.

Protocol 6. Preparation of RPMI buffer for Stock Solution.
To prepare 1 liter liquid medium:
1. Measure out 800 mL distilled water and pour into a mixing container that is as close to
the final volume as possible.
2. Add 10.4 g powdered RPMI medium (GIBCO) to 15 to 30 oC (room temperature) water
with gentle stirring (Do not heat water).
3. Rinse out inside of package to remove all traces of powder
4. Add 34.5 g MOPS sodium salt (3-(N-morpholino) propanesulfonic acid), Fluka) into the
medium
5. Dilute to a desired volume with water. Stir until dissolved.(Do not over-mix)
6. Adjust PH of medium to 0.2-0.3 below desired final working PH (7.0): use of 1N NaOH
is recommended. (Add slowly with stirring). After pH has been adjusted. Keep container
closed until medium is filtered
7. Sterilize immediately by 50 mm Diameter Filter Unit (150 mL or 250 mL, NALGENE)
(Positive pressure recommended), and pH units usually rise 0.1-0.3 upon filtration and
reach to 7.0
8. Label
9. Store @ 4 oC

Protocol 7. Preparation for 10% Glycerol/RPMI Buffer Stock Solution (100 mL)
1. Prepare 10% glycerol /RPMI buffer stock solution:
90 mL RPMI buffer (RPMI 10.4 g/L H2O, MOPS 34.5 g/L H2O)
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10 mL glycerol
Combine RPMI Buffer & Glycerol—VORTEX (for 2 min)
2. Filter sterilizes (0.45 microns)
3. Label
4. Store at 4 oC

Protocol 8. Inoculum Stock Solution (Long term)
1. Add 50 µL of inoculums to 1 mL RPMI Buffer/Glycerol (10% stock solution) in 5 mL
round bottom tube
2. Vortex
3. Label and parafilm tube
4. Falcon Blue Max Jr., Falcon Max polypropylene Conical Tubes and Cryogenic vials can
be used for storage at 4 oC
5. Select Isolate for Storage
6. From prepared conidial suspension pour off supernatant-add 5 mL of 10%
Glycerol/RPMI Buffer stock spores (only)
7. Votex-pipette 0.5 mL conidial suspension into each cryogenic vial
8. Store at -80 oC

Protocol 9. Silica Gel Storage of Fungal Isolates (Long-term)
Using sterile technique, equipment and laminar flow food:
1. Shake gently but thoroughly the tube of milk suspension; flame the mouth of the tube.
2. Pour the milk suspension onto fungal growth in petri dish. Sometimes 2 tubes of milk
suspension will be needed if the isolate exhibits a “fluffy” growth pattern.
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3. Using a sterile glass rod, scrape the entire surface of the fungal culture to dislodge
conidia – rotate dish gently to move milk over surface of the fungal growth.
4. Label the tube of silica gel to be used for storage; include the name of the isolate and the
date (Example: Goff 9/10/96 skim or dry milk ).
5. Remove screw cap from silica gel tube. Remove cotton stopper with sterile forceps,
flame the mouth of the tube.
6. Using a sterile Pasteur pipette with a small pipette bulb attached, transfer 0.5ml – 2.0ml
of the conidial-milk suspension into the silica gel tube. Flame the mouth of tube again;
replace cotton stopper and screw cap securely.
7. Immediately Vortex. Place tube on Vortex mixer and allow shaking vigorously, turning
the tube so that the conidial-milk suspension is mixed well onto the silica gel crystals.
The tube of silica gel will begin to heat when the milk suspension makes contact with the
crystals.
8. After the milk suspension has been combined well with the silica gel, plunge the tube
into an ice bath to keep the contents from getting hot enough to kill the fungus. Be sure
the tube has the cap screwed tightly to prevent moisture from entering the tube.
9. After the tubes have cooled in the ice bath they may be stored in the refrigerator for an
indefinite period of time.
10. To start a fresh fungal culture from silica gel storage – shake out a few crystals onto
prepared medium (PDA or Oatmeal-PDA) in petri dishes and allow fungus to grow.
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Protocol 10. Target Range for %T (625 nm) for Conidia Concentrations
BECKMAN
Fungus

SHIMADZU

Target Range

%T for

Target Range

%T for

for %T (625

1×10^6

for %T (625

1×10^6

nm)

CFU/mL

nm)

CFU/mL

B. cinerea

8 --- 62

39

27 --- 79

60

C. acutatum

2 --- 79

56

20 --- 83

64

C. fragariae

15 --- 70

55

30 --- 77

67

C. gloeosporioides

37 --- 72

61

50 --- 78

69

C. gloeosporioides 162

34 --- 65

55

51 --- 77

68

F. oxysporum

30 --- 65

55

49 --- 78

70

P. obscurans

46 --- 80

77

50 --- 77

75

P. viticola

37 --- 69

6

48 --- 76

67

*Inoculum must be within the ranges showed on the table for bioautography and microtiter assay.
The target range for %T is the ideal point for fungus growth; CFU=Colony Forming Units.

Protocol 11. McFarland 0.5 Barium Sulfate Turbidity Standard
1. McFarland Standard consists of 50uL 0.048mol/L BaSO4 stock solution and 9.95 mL
0.18 mol/L H2SO4 stock solutions.
2. H2SO4 stock solution: 0.18 mol/L H2SO4 (stock solution: 1mL conc. H2SO4 + 99 mL
H2O.
3. Barium chloride stock solution: 0.048mol/L BaCl stock solution (1.175g BaCl*2 H2O:
99mL H2O).
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4. 0.5 McFarland standard % T (625 nm) = 70%
5. Goes bad: make up every 3months.

Protocol 12. Spotting and Spraying TLC plates for Bioautography
Make 20 mg/mL of test samples: weigh the test samples and then adding the corresponding
solvents.
1. Label with date, fungal isolate, and name and/or sample designation on the top of the
plate.
2. For each essential oil treatment add 4 uL and 8uL onto different lineated sections on the
plate.
3. Spray fungal spore solution on the plate; remember to hold the plate as flat as possible,
silica side up (spray once and allow to dry then completely cold the plate in the spore/
media solution and second time before placing directly into chamber).
4. Place in moisture chamber and then into 250 oC incubator for 4 days.
5. Measure the diameter of inhibitory zones and make any other observations you can about
the plates.

Protocol 13. Procedures for Grape Media
Wash and rinse grape leaves (20 leaves) with DDI H2O. Allow the leaves to drain (paper towel)
to remove excess water. Using a Waring Commercial Blender grind Grape leaves (with 500 mL
DDI H2O). Pure the suspension into 500 mL erlenmeyer flask with a stir bar in it. Stir (Sti/Hot
plate-No Heat!) until completely blended. Check pH of media (pH of Grape broth is around 3.0)
and adjust it until 6.5 using 1 M NaOH. Wrap mouth of flask with folded aluminum foil and seal
with autoclave tape. Sterilize at 121 °C for 45 minutes.
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Protocol 14. Procedures for Agar Media
20 g Bacto Agar
1000 mL DDI H2O
Using a 1000 mL erlemeyer flask combine agar and water. Stir (Stir/Hot plate) and heat until
completely blended. Divide media into 500 mL aliquots in 1000 mL Erlenmeyer flask (to allow
for volume during autoclaving). Wrap mouth of flask with folded aluminum foil and seal with
autoclave tape. Sterilize at 121 for °C 45 minutes.

Protocol 14. Procedures for Strawberry Agar Media
500 mL Grape Media
500 mL Agar media
Using cooled sterilized Grape media pour into flask containing cooled agar media. Combine
media and reseal flask with sterile aluminum foil removed from containing Agar media. Mix
them well and pour plates in sterile hood while media is warm. Do not allow media to get cold.

Protocol 15. Murashige and Skoog Supporting Solution
1. M&S Basal Salt Mixture (Sigma M5524)

2.2 g/L

2. Sucrose (Sigma S8501)

10 g/L

3. Gamborg's Vitamins

5 mL (of a 100x prepared solution) /L

4. pH 5.7
5. Phytagel (Sigma P8169)

1 g/L

Protocol 16. MES with Sucrose
1. (2-[N-Morpholino] ethane sulfonic acid) hydrate (Sigma M8250)
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1 mM in water

2. Sucrose (Sigma S-8501)

2% W/V

3. pH 6.5
4. Phytagel (Sigma P8169)

1 g/L

Protocol 17. Hoagland Solution
1. Hoagland Basal salts (Phytotechnology Laboratories, P.O. Box 13481, Shawnee Mission, KS
66282

3.2 g/L

2. Phytagel (SigmaP8169)

1 g/L

Protocol 18. Preparation of Difco Mycological Broth
Yeast

40 g

Mycological Broth

100 g

Sucrose

400 g

DDI H2O

2L

pH

4.8

Heat and stir

Protocol 19. Preparation of Shredded Wheat Medium
200 mL

Difco mycological broth

100 g

shredded wheat

put in 2.0 L

Fernbach flask

Autocalve for 45 min @ 121 °C
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Protocol 20. Preparation of 2% Malt Extract Agar (MEA) Medium
200 mL of 2% MEA medium:
Malt extract 2% × 200 = 4 g
Peptone 0.1% × 200 = 0.2 g
Glucose 2% × 200 = 4 g
Agar 2% × 200 = 4 g
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APPENDIX: B

1D and 2D NMR and UV Data of the Pure Compounds
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1

H NMR spectrum of 4-hydroxy-5, 6-dimethoxy-2-naphthaldehyde (9)
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HMBC spectrum of 9
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UV of 9
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1

H NMR spectrum of 12, 13-didehydro-20, 29-dihydrobetulin (10)
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C NMR spectrum of 10
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H NMR spectrum of 7-methyljuglone (11)
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H NMR spectrum of diospyrin (12)
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H NMR spectrum of isodiospyrin (13)
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H NMR spectrum of shinanolone (14)
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H NMR spectrum of lupeol (15)
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H NMR spectrum of betulinic acid (17)
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H NMR spectrum of mitragynine
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H NMR spectrum of cladosporin (20)
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H NMR of isocladosporin (21)
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H NMR spectrum of asperentin-8-methyl ether (34)
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H NMR of 6, 5’-diacetyl cladosporin (36)
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Antifungal Metabolites from the Roots of Diospyros virginiana by Overpressure Layer
Chromatography
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A preparative overpressure layer chromatography (OPLC) method was successfully used
for the separation of two new natural compounds, 4-hydroxy-5,6-dimethoxy-2-naphthaldehyde
(1) and Δ12,13-20,29-dihydrobetulin (2) together with nine known compounds including 7methyl-juglone (3), diospyrin (4), isodiospyrin (5), shinanolone (6), lupeol (7), betulin (8),
betulinic acid (9), betulinaldehyde (10), and ursolic acid (11) from the acetone extract of the
roots of Diospyros virginiana. Their identification was performed with mono and bidimensional
NMR spectroscopy and HR-ESI-MS methods. All the isolated compounds were evaluated for
their antifungal activity against Colletotrichum fragariae, C. gloeosporioides, C. acutatum,
Botrytis cinerea, Fusarium oxysporum, Phomopsis obscurans, and P. viticola using in vitro
micro-dilution broth assay. The results indicated that compounds 3 and 5 showed high antifungal
activity against P. obscurans at 30 µM with 97.0 % and 81.4 % growth inhibition and moderate
activity against P. viticola (54.3 % and 36.6 %). It appears that an optimized OPLC system offers
a rapid and efficient method of exploiting bioactive natural products.

Introduction. −Discovery of new crop protections from natural products has received
considerable interest as alternatives to synthetic agrochemicals for use as pest and disease control
agents. This stems from these generally being safer for human health and the environment.
Biologically active natural products can be used in modern crop protections or can serve as lead
structures for the development of new semi-synthetic analogs. Our current research efforts are to
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identify natural product-based fungicides. In this research program, we evaluated 37 plant
extracts using a direct bioautography bioassay to detect antifungal activity against
Colletotrichum. Of these, Diospyros virginiana root extract showed the most promising activity.
Based on preliminary screening results, a bioassay-guided fractionation of D. virginiana root
extract was conducted in order to isolate and identify the pure metabolites possessing antifungal
activity. Diospyros belongs to the family Ebenaceae that contains approximately 500 species of
trees and shrubs [1], of which more than 350 species are distributed in tropical and subtropical
regions worldwide [2-3]. The most well-known species is Diospyros kaki, which originated in
East China and has been cultivated in Japan for centuries [4]. Some of the Diospyros species,
such as D. peregrina and D. melanoxylon, have been used in folk medicine for the treatment of
inflammation, urinary discharges and enrichment of blood [5]. Diospyros virginiana, the
American persimmon, is native to North America and the fruits were reported to show
cholesterol lowering activity, and usefulness to treat bloody stools, thrush and sore throats [6].
The literature shows reports of nine compounds being isolated and identified from either the
leaves or the wood of D. virginiana [7-9]. However, there are no reports in the literature on
chemical fractions from the roots of D. virginiana.
OPLC was developed by Tyihák and Mincsovics in the late seventies [10]. In this process, a
TLC plate is covered by a sheet of flexible material and subjected to a high external pressure.
The high external pressure, which is generated by a programmable pump, pushes the mobile
phase through the analytical or preparative adsorbent layer. This allows a faster separation and
more compact spots than conventional TLC. Generally, the Rf of the migrated compounds is two
to five times greater than in conventional TLC. OPLC also offers an advantage over traditional
TLC as it is a sealed system, which results in less solvent loss through evaporation [11-12]. As
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such, OPLC has been widely used in analytical and preparative applications [13-15]. Compared
to conventional methods, OPLC offers a more rapid and reliable method for the isolation of
naturally occurring compounds. In the present paper, we report the use of a preparative OPLC
technique to isolate co-migrating bioactive metabolites from the roots of Diospyros virginiana.

Results and Discussion. −The roots of D. virginiana were extracted using acetone in a
Soxhlet extractor. The constituents of this extract were separated by flash chromatography,
OPLC and preparative TLC. A new naphthyl derivative, 4-hydroxy-5,6-dimethoxy-2naphthaldehyde (1), and a triterpene, Δ12,13-20,29-dihydrobetulin (2) were isolated from a natural
source for the first time, along with nine known compounds: 7-methyl-juglone (3) [16],
diospyrin (4) [17], isodiospyrin (5) [16-18], shinanolone (6) [19], lupeol (7) [20], betulin (8) [21],
betulinic acid (9) [22], betulinaldehyde (10) [23], and ursolic acid (11) [24]. Although they are
common in most of the Ebenaceae family [5], compounds 10 and 11 were isolated for the first
time from D. virginiana. The structures of the known compounds were confirmed by comparison
of their spectroscopic data (MS, 1H and 13C NMR) with literature values.

The HR-ESI-MS of compound 1 indicated a molecular formula C13H12O4 and its IR
spectrum exhibited characteristic absorption bands for hydroxyl and conjugated carbonyl groups.
The 1H NMR spectrum showed signals for an aldehyde group at δ 10.03 ppm, one aromatic AB
system at δ 7.37 (d, J = 9.0 Hz) and 7.78 (d, J = 9.0 Hz). The above data suggested a 2naphthaldehyde structure with the presence of two methoxyl groups at δ 4.06, and 4.13 ppm, and
a hydroxyl substituent at δ 9.75 ppm. The 13C-NMR spectrum showed thirteen signals with ten
typical aromatic carbons. Assignment of structure was accomplished by HMBC experiment. The
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NOESY experiment showed a correlation between the methoxyl group at δ 4.06 and H-7 (δH
7.37, d) and methoxyl group at δ 4.13 and the hydroxyl signal at δ 9.75 ppm, corroborating the
location of the methoxyl groups at C(5) and C(6). Thus, 1 was characterized as 4-hydroxy-5,6dimethoxy-2-naphthaldehyde.

Compound 2 was obtained as a white solid. The molecular formula was determined as
C30H51O2 by HR-ESI-MS ([M + H]+ at m/z = 443.3874). The 13C NMR data of 2 indicated the
presence of 30 carbons comprising seven methyl groups, ten methylenes, seven methines and six
quaternary carbons. The seven methyl groups resonated at δH 0.79 (s, 6H), 0.93 (d, 6H, J = 6.8),
0.98 (s, 3H), 0.99 (s, 3H), and 1.10 (s, 3H) in the 1H NMR spectrum indicating the lupane
triterpene skeleton for 2 [25]. The 13C NMR spectrum also revealed the presence of one olifenic
methine (δ(C) 125.0) correlated in the HMQC spectrum with the proton at δ(H) 5.20 (H-C(12)).
The last proton showed HMBC correlation with C(9), C(14), and C(18), this correlation led to
the placement of the double bond between C(12) and C(13). This was confirmed by the COSY
correlation between H-C(12) (δ(H) 5.20) and H2-C(11) (δ(H) 1.90) and further supported by the
HMBC correlation of H3-C(27) (δ(H) 1.10) and C(13) (δ(C) 136.7) (Fig. 1). From these data, the
compound 2 was deduced to be Δ12,13-20,29-dihydrobetulin. This is the first report for the full
spectral data and isolation of 2 from a natural source, although it has been prepared synthetically
and only the 1H NMR data was reported [26].

The antifungal activity of compounds 1-11 was examined using a 96-well micro-dilution
broth assay against the plant pathogens: Botrytis cinerea, Fusarium oxysporum, Phomopsis
obscurans, P. viticola and three Colletotrichum species. Phomopsis species were the most
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sensitive fungi to these compounds. 7-methyl-juglone (3) and isodiospyrin (5) showed the most
antifungal activity against P. obscurans. Compound 3 showed 97.0 % growth inhibition of P.
obscurans at 120 h at 30 µM, whereas compound 5 showed 81.4 % growth inhibition. The
antifungal activity of 3 and 5 at 30 µM against P. viticola was 53.4% and 57.7%, respectively.

The newly reported compounds, 4-Hydroxy-5, 6-dimethoxy-2-naphthaldehyde (1) and
Δ12,13-20,29-dihydrobetulin (2) at 30 µM showed weak antifungal activity with 26.9 % and 22.1
%, respectively (Fig. 2). Compound 3 and compound 5 at 30 µM caused 54.3 % and 36.6 %
growth inhibition of P. viticola at 120 h. Any test compound possessing <50% growth inhibition
at 30 µM is considered to have weak antifungal activity in this bioassay. Compound 1 was more
active against P. vitricola at 120 h than at 144 h. This response is often seen when an inducible
enzyme system is turned on and a compound is detoxified by the fungus. However, the upward
slope of the graph for compound 1 in Fig 3 from the low to high concentration is indicative of
precipitation in the aqueous microdilution broth assay. Because the microtiter plate reader
measures changes in optical density it does not discriminate between fungal growth and
precipitation. Compound 1 appears to have come out of solution at the higher concentration (30
µM) in the P. viticola testing (Fig 3). Lipophilic compounds are problematic in in vitro aqueous
bioassays and follow-up antifungal testing will take place using a detached leaf bioassay [27].
Interpretation of the graphical results indicate that compounds 2, 3, and 5 appear to remain
soluble at 120 h and 144 h.
Commercial fungicides standards captan and benomyl are significantly more active than
any of the compounds tested.

Azoxystrobin, which is commercially used to control

Colletotrichum and Botrytis diseases, shows poor activity against P. viticola. Both captan and
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azoxystrobin show 100% growth inhibition at 3 µM against P. obscurans.

Although once an

excellent agent for controlling anthracnose and other diseases of strawberries and ornamentals,
resistance developed by pathogens has resulted in benomyl being less useful [28]. While the test
compounds appear inherently antifungal, we hypothesize that these compounds are probably
present in the plant as constitutive defense compounds that act to deter infection or fungal
growth. Since these compounds were found without elicitation they are probably constitutive in
nature [29-30] and may have a potential role in preventing fungal infection in D. virginiana.

Conclusions. − Using a bioassay-guided fractionation of the acetone extract D.
virginiana were able to isolate the antifungal constituents of the roots of this plant. This research
demonstrates that OPLC is a powerful technique that can be used to separate and isolate comigrating natural products produced by plants. These constituents were tested for the first time
against Colletotrichum spp, B. cinerea, F. oxysporum, P. obscurans, and P. viticola. The most
promising agricultural lead compounds against the pathogen P. obscurans are 3 and 5.
Phomopsis leaf blight and fruit rot is a serious disease with strawberries and causes serious
economic loss of this fruit each year. Our results suggest that compounds 3 and 5 warrant further
in vivo testing as plant protectants to control Phomopsis species [27].
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Experimental Part
Chemistry
General. UV spectra were obtained in MeOH using a Varian Cary 50 spectrophotometer
and IR spectra were recorded using Bruker Tensor 27 spectrophotometer. 1H- and

13

C-NMR

spectra were obtained on Bruker model AMX-500 and 400 NMR spectrometers with standard
pulse sequences, operating at 500 and 400 MHz for 1H and 125 and 100 MHz for

13

C. High

resolution electrospray ionization mass spectroscopy (HR-ESI-MS) was recorded on a
Micromass Q-Tof Micro mass spectrometer with a lock spray source. OPLC separations were
performed with the Personal OPLC 50 instrument (OPLC-NIT, Budapest, Hungary) at 50 bars
external pressure. OPLC silica gel layer, F254 20 × 20 cm on glass plate (LG 011, OPLC-NIT Ltd,
Budapest Hungary) with 200 µm sorbent thickness, 11 µm particle size, 6 nm pore size, and 20 ×
20 cm on aluminum sheet (BSLA 001, OPLC-NIT Ltd, Budapest Hungary) with 200 µm sorbent
thickness, 5 µm particle size, 6 nm pore size. An AS-30 sample applicator (DESAGA, Wiesloch,
Germany) was used for the sample application. Classical TLC analysis was performed on silica
gel 60 F254 20 × 20 cm on aluminum sheet (Gibbstown, New Jersey, USA). Detection was
carried out under UV light (254 nm, 366 nm) and visualization made with vanillin-H2SO4 (1 g
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vanillin in 100 ml of 20 % H2SO4 in EtOH) reagent followed by heating at 105 ºC for 5 min.
ACS-grade solvents, acetonitrile, acetone, chloroform, dichloromethane (DCM), diethyl ether,
ethyl acetate (EtOAc), EtOH, n-hexane, isopropanol (IPA), methanol and toluene from Fisher
Scientific (New Jersey, USA) were used for silica gel column chromatography and TLC
separations. HPLC-grade solvents (acetonitrile, chloroform and DCM) from Sigma-Aldrich (St.
Louis, USA) were used for OPLC chromatograms.

Plant material. The roots of D. virginiana were collected from the Missouri Botanical
Garden, U.S.A., in June 2009. The plant material was identified by Dr. Vaishali C. Joshi, and a
voucher specimen CON310700-2-A was deposited at the National Center for Natural Products
Research, School of Pharmacy, University of Mississippi.

Extraction and Isolation. Dried powdered roots (66 g) were extracted in a Soxhlet extractor
with acetone (600 ml) for 8 h and the extract was subsequently evaporated under vacuum to yield
the dry residue (2 g). The crude extract was fractionated on a silica gel column (100 g, 50 × 5 cm,
ChemGlass) using n-hexane (500 ml), 5 % EtOAc in n-hexane (600 ml), chloroform (600 ml), 5
% IPA in chloroform (600 ml) and methanol (600 ml), respectively. Four fractions were obtained
in total F-1 to F-4. Direct-bioautography guided assay showed that the activity was found to
reside in F-1 (120 mg) and F-2 (240 mg), with some activity in F-3 (710 mg), while F-4 (800 mg)
did not show activity against three notorious plant pathogenic fungi of the Colletotrichum
species. A portion of F-1 (10 mg) showed one major product and was purified using preparative
TLC (SiO2, n-hexane-chloroform 1:1) to furnish 7-methyl juglone (3, 1.5 mg). A portion of F-2
(20 mg) was purified using OPLC with DCM as the eluent. Elution conditions were as follows:
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flash volume, 300 µl; eluent volume, 30,000 µl; flow-rate, 500 µl min-1; development time, 3606
s; external pressure, 50 bars. Eighty-eight sub-fractions (1 ml / fraction) were obtained in total, of
which sub-fractions 49-54 gave betulinaldehyde (10, 0.8 mg). Sub-fractions 72-88 afforded
ursolic acid (11, 1.3 mg). Sub-fractions 28-37 were combined (7.9 mg) and further purification
was performed by OPLC with n-hexane-ether (6/4, v/v, 20,000 µl; flash volume, 300 µl; flowrate, 500 µl min-1; development time, 2406 s) as eluent and 66 sub-fractions (1 ml / fraction)
were obtained, among which sub-fractions 10'-18' furnished lupeol (7, 2 mg). Sub-fractions 19'66' (marked as fraction A) were combined to give a mixture of 3.6 mg containing four
compounds with close Rf values in several TLC systems (SiO2, n-hexane-EtOAc 6:4, DCM-IPA
9:1, CHCl3-MeOH 19:1). In order to obtain enough material for further purification, OPLC
procedures were repeated six times for F-2 using the same conditions, then fraction A (19.6 mg)
was obtained and purified by OPLC with DCM (100 %, 20,000 µl; flash volume, 300 µl; flowrate, 400 µl min-1; development time, 3007 s) as mobile phase. Sub-fraction 12″ yielded a new
product 4-hydroxy-5, 6-dimethoxy-2-naphthaldehyde (1, 1 mg). Sub-fractions 9″-11″ gave
diospyrin (4, 2 mg). Sub-fractions 14″-21″ afforded isodiospyrin (5, 2 mg). Fraction 3 (24 mg)
was chromatographed using OPLC with CHCl3-EtOAc (95/5, v/v, 40,000 µl) with flash volume
300 µl, flow rate 500 µl min-1 and an elution time of 4806 s. One hundred and twenty-three subfractions (1 ml / fraction) were collected. Sub-fractions 54-66 yielded betulin (8, 3.4 mg). Subfractions 67-90 (7.4 mg), containing at least four compounds, were purified by OPLC with
CHCl3-acetonitrile (98/2, v/v) and flash volume 300 µl, flow rate 300 µl min-1 and a total elution
time of 4806 s. Sub-fractions 79'-87' gave shinanolone (6, 1.5 mg). The other minor compounds
were in such small quantity that they were impossible to isolate. In order to obtain enough
material for further purification, flash chromatography of F-3 (400 mg) using a BIOTAGE
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(Isolera One) with CHCl3-EtOAc (0-5 %, 200 ml) and CHCl3 (100 %, 201 ml-640 ml), and flow
rate, 5 ml min-1 (Si, SNAP 25 g column) was conducted. A total of 81 sub-fractions (1
ml/fraction) were collected. Subfractions 38-51 were combined to yielded a 30 mg mixture. This
mixture was subjected to the OPLC system with CHCl3-acetonitrile (98/2, v/v, 40,000 µl) with
flash volume 300 µl, flow rate 250 µl/min and total elution time 9624 s. One hundred and eightythree subfractions (1 ml / fraction) were obtained. Subfractions 100-112 were combined and
identified as betulin (8, 2 mg). Subfractions 136-144 yielded betulinic acid (9, 1 mg). Subfraction
114-126 gave a new triterpene, Δ12,13-20,29-dihydrobetulin (2, 1 mg) as a natural product.
4-hydroxy-5,6-dimethoxy-2-naphthaldehyde (1): Yellow amorphous solid; UV (MeOH):
λmax nm (log ε): 375 (4.1), 320 (4.2), 270 (3.8); IR (neat): νmax 3332, 2923, 2851, 2360, 2341,
1687, 1372, 1274, 1055 cm-1; 1H- NMR (500 MHz, CDCl3): δ 4.06 (3H, s, OMe), 4.13 (3H, s,
OMe), 7.29 (1H, s br, H-C(3)), 7.37 (1H, d, J= 9.0 Hz, H-C(7)), 7.78 (1H, d, J=9.0 Hz, H-C(8)),
7.81 (1H, s br, H-C(1)), 9.75 (1H, OH-C(4)), 10.03 (1H, s, H-C(11));

13

C-NMR (125 MHz,

CDCl3): δ 56.67 (OMe), 62.20 (OMe), 106.14 (C(3)), 115.46 (C(7)), 121.49 (C(10)), 126.02
(C(1)), 127.19 (C(8)), 130.120 (C(9)), 134.09 (C(2)), 143.46 (C(5)), 149.95 (C(6)), 154.28
(C(4)), 191.79 (C(11)); HR-ESI-MS: m/z = 233.0812 ([M + H]+, C13H13O4; calc. 233.0814).
Δ12,13-20,29-dihydrobetulin (2): White amorphous solid; [α]20D = +79.2 (c 0.05, MeOH ); IR
(KBr): νmax 3340, 2940, 2867, 1446, 1372, 1027 cm-1; 1H-NMR (400 MHz, CDCl3): δ 0.73 (1H,
d, J=7.2 H-C(5)), 0.79 (6H, s, Me-24, Me-26), 0.89 (1H, m, , H-C(20)), 0.93 (6H, d, J= 6.8 Hz,
Me-29, Me-30), 0.98 (3H, s, J=9.0 Hz, Me-25), 0.99 (3H, s, Me-23), 1.10 (3H, s, Me-27), 1.201.81 (8CH2), 1.90 (2H, m, H2-C(11)), 3.19 (1H, d, J=10.4, H-C(28ª)), 3.22 (1H, m, H-C(3)), 3.53
(1H, d, J=10.4, H-C(28b)), 5.13 (1H, bs, H-C(12)); 13C NMR (100 MHz, CDCl3): δ 15.6 (C(29)),
15.7 (C(24)), 16.7 (C(25)), 17.3 (C(26)), 18.3 (C(6)), 21.3 (C(30)), 23.2 (C(21)), 23.3 (C(27)),
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23.4 (C(11)), 25.9 (C(2)), 27.2 (C(15)), 28.1 (C(23)), 30.6 (C(16)), 32.8 (C(7)), 35.2 (C(1)), 36.9
(C(14)), 38.7 (C(22)), 38.0 (C(4)), 39.3 (C(20)), 39.4 (C(19)), 40.0 (C(10)), 42.0 (C(8)), 42.3
(C(17)), 47.6 (C(18)), 54.0 (C(9)), 55.1 (C(5)), 69.9 (C(28)), 79.0 (C(3)), 125.0 (C(12)), 136.7
(C(13)). HR-ESI-MS m/z = 443.3874 ([M + H]+, C30H51O2; calc. 443.3889).

Biological Assay
Direct-bioautography assay. Bioautography procedures were described in our previous
studies [31-32]. The acetone extract of D. virginiana roots was applied at 80 and 160 µg/spot in
chloroform onto a silica plate. Technical fungicide grade standards benomyl, cyprodinil,
azoxystrobin, and captan (Chem Service Inc., West Chester, PA) were used as positive controls at
2 mM in 2 µl of 95% ethanol. TLC profiles of F-1 to F-4 in chloroform were tested against
Colletotrichum spp and mild polar compounds appear to be responsible for antifungal activity.
Micro-dilution broth assay. A standardized 96-well micro-dilution broth assay developed
by Wedge and Kuhajek [33] was used to evaluate the antifungal activity of pure compounds from
D. virginiana that were identified as active by bioautography.
Isolates of Colletotrichum acutatum Simmonds, Colletotrichum fragariae Brooks,
Colletotrichum gloeosporioides (Penz.) Penz & Sacc. In Penz, Botrytis cinerea Pers.:Fr,
Fusarium oxysporum Schlechtend:Fr, Phomopsis obscurans (Ellis and Everh.) B. sutton, and P.
viticola Sacc., were used to evaluate the antifungal activity of the test compounds using in vitro
micro-dilution broth assay. Each fungus was challenged in a dose-response format using test
compounds where the final treatment concentrations were 0.3, 3.0 and 30.0 µM. Technical grade
commercial fungicides captan, azoxystrobin, and benomyl, which represent three different modes
of actions, were used as positive fungicide standards.
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Each compound was evaluated in

duplicate and the experiment was performed three times in time. Mean absorbance and standard
errors were used to evaluate fungal growth after 48 and 72 h, except for P. obscurans and P.
viticola (120 and 144 h).
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Figures Legends
Fig. 1. Relevant 1H-13C HMBC (→) and 1H-1H COSY (↔) correlations of 2
Fig. 2. Mean fungal growth inhibition (%) of Phomopsis obscurans after exposure to 1, 2, 3 and
5 using a dose-response format at 120 and 144 h. Abreviations: Cap: Captan; Azo: Azoxystrobin;
Ben: Benomyl
Fig. 3. Mean fungal growth inhibition (%) of Phomopsis viticola after exposure to 1, 2, 3 and 5
using a dose-response format at 120 and 144 h. Abreviations: Cap: Captan; Azo: Azoxystrobin;
Ben: Benomyl
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Fig.1. Relevant 1H-13C HMBC (→) and 1H-1H COSY (↔) correlations of 2
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Fig. 2. Mean fungal growth inhibition (%) of Phomopsis obscurans after exposure to 1, 2, 3 and
5 using a dose-response format at 120 and 144 h. Abreviations: Cap: Captan; Azo:
Azoxystrobin; Ben: Benomyl
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Fig. 3. Mean fungal growth inhibition (%) of Phomopsis viticola after exposure to 1, 2, 3 and 5
using a dose-response format at 120 and 144 h. Abreviations: Cap: Captan; Azo: Azoxystrobin;
Ben: Benomyl
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Abstract

Introduction
Fruit rot diseases of strawberry (Fragaria x ananassa Duch.) are serious problems for
strawberry producers in many areas of the world [1](Maas, 1998) and are particularly severe in
the southeastern United States where diseases are often enhanced by warm temperatures and
frequent rains during the harvest season. Losses by Florida strawberry growers due to disease
were estimated to be 10 to 15% of the crop whose farm gate revenue averages over $100 million
each season [2] (Legard, et al., 1997). Anthracnose diseases caused by Colletotrichum spp.
[3,4,5] (Smith, 1998a, 1998b, 1998c) can be especially devastating since other plant parts may be
infected in addition to the fruit.
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Effective disease control strategies for crop plant pathogens often rely on the use of
fungicides. Wedge et al. [6], reported on new fungicide management strategies for control of
strawberry fruit rot diseases in the Gulf state region and the need for efficacious fungicides to
provide growers with more options for controlling disease.

Disadvantages of the use of these

chemical controls include the development of resistant fungal strains as well as potential
environmental and mammalian toxicities. Resistance of many plant pathogens to commonly
used commercial fungicides is becoming a serious problem and has limited the number of
effective disease control agents. Numerous isolates of Colletotrichum spp. developed benomyl
insensitivity after several years of use to protect strawberry and other fruit crops [7,8] (Peres et
al., 2002, 2004; [9,10]Smith and Black, 1993 a-b). Colletotrichum species often cause typical
symptoms of anthracnose, a disease characterized by sunken necrotic lesions usually bounded by
a red margin [11,12] (Freeman et al., 1998; Wedge et al., 1999). Anthracnose diseases of
strawberry (Fragaria × ananassa Duch) are serious problems for fruit and plant production in
many areas of the world [14] (Maas, 1998). The pathogens, Colletotrichum fragariae A. N.
Brooks, C. gloeosporioides (Penz.) Penz., and C. fragariae CF -75, can occur singly or in
combination, and can infect flowers, fruit, leaves, petioles, stolons, and crowns (Howard et al.,
1992; [15,3,4,5] Smith 1998 a, b, c).
Fungicide discovery efforts at the USDA–ARS, Natural Products Utilization Research
Unit, National Center for Natural Products Research, University, MS, are focused on natural
products derived from plants and marine organisms with emphasis on compounds with
fungicidal activity [16] (Wedge and Kuhajek, 1998). Along with discovery of new chemistry
and our interest in antimicrobial agents from higher plants [17] (Zhou and Wedge, 2007), we
have also had to developed novel miniaturized bioassays for evaluating small amounts of
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available compound [18,19] (Wedge and Smith, 2006; Abril et al., 2008). Natural antimicrobial
agents from plants are generally broad-spectrum compounds with low mammalian and
environmental toxicity [17] (Zhou and Wedge, 2007).
Development new plant protectants with a lipophilic nature are limited by the lack of
suitable bioassays to properly evaluate these compounds. While the lipophilic nature of
phytochemicals and marine compounds allows them to embed themselves into the leaf waxes
and persist through rainfall, hence making them potentially useful agrochemicals, this
characteristic also makes them very difficult to evaluate in many bioassays. Essential oils and
many marine extracts are hydrophobic and insoluble in most aqueous-based antimicrobial disc
diffusion and micro-dilution broth bioassays. Direct bioautography on silica gel is our preferred
primary screening bioassay and often the best assay for evaluating lipophilic compounds as
fungicides for agricultural use because this assay more closely mimics a leaf surface. Classical
leaf bioassays used to test fungicide efficacy at concentrations between 625 and 2500 ppm may
use 75-100 mg of an experimental compound that is often difficult to obtain. Therefore the need
for a novel miniaturized leaf disk bioassay that utilizes small sample sizes, has high throughput
capability, and replicates the real leaf surface is of utmost importance to natural product
fungicide discovery. This paper presents information about our progress in developing of a new
24-well detached leaf bioassay and we discuss problems associated with evaluating natural
product fungicides.

Experimental

Plant preparations
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Anthracnose-susceptible ‘Chandler’ plants were obtained in October 2007 from
Shingleton Farms (Statonsburg, NC, USA), planted into 14 cm plastic azalea pots containing
Metromix 350 (BWI- Memphis, TN), and placed in the greenhouse without shade. Plants were
watered daily and weekly with Peter’s 20-20-20 nutritional solution (BWI- Memphis, TN).
Plants with any signs of anthracnose or wilt disease were rouged and removed from the
greenhouse daily.

24-well Leaf Disk Assay
Three commercial in vitro salt solutions were evaluated for their ability to maintain leaf
disks during the in vitro experiment. Half strength Hoagland’s No. 2 (H, Phytotechnology
Laboratories, Shawnee Mission, KS), 2-N-morpholino ethanesulfonic acid (MES, Sigma M8250,
Sigma-Aldrich, St. Louis, MO), Murashige and Skoog basal salt mixture (MS, Sigma M5524),
and water (control) were evaluated for their ability to sustain excised leaf discs for 7-10 days.
Stock solutions containing 1% Phytogel (Sigma P8169) were prepared as follows: Hoagland’s
No. 2 solution (0.815 g/L), MES (195.2 mg/L) containing 5 mL Gamborg's Vitamins (ThiamineHCl 5 mg/L, Pyridoxine-HCl 0.5 mg/L, Nicotinic acid 0.5 mg/L, Myo-inositol 50mg/L), and
MS (2.2 g/L). All support solutions were adjusted to 6.5 pH using 1 N NaOH and 0.1 N NaOH.
Excised leaf discs were placed onto the 1500 µL of either respective solidified salts/medium
contained in each well of the 24-well plate. Plates were maintained in the sterile biological hood
overnight prior to pathogen inoculation to allow time for the leaf disks to initiate wound healing
and acclimate to the in vitro system. 24-well were plates were sealed with paper-based tape and
placed in the incubator under (55±5 µmols·m-2·sec-1) Ushio Ultra 8 fluorescent lights (UFLF17T8/741, Interlectric Corp., Warren, PA) with a 12 h photoperiod in a growth chamber at 25º
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C for one week. All samples were done in duplicate and the experiments were repeated three
times in time.

Leaf disc preparation
The first or second fully expanded leaves were removed from stock strawberry plants and
transported directly to the laboratory so that the leaves were available for the bioassay in less
than 4 hours. Immediately after collection, the leaves were placed in a tray lined with moist
paper towels and the tray was closed to retain near 100% relative humidity (RH) and maintained
at ~12°C. Only leaves with no visible signs of injury or symptoms of disease were collected.
Whole leaves were disinfested by placement in a beaker with 2.5% Clorox for 3 min., leaves
were rinsed 2-3 minutes in sterile DDI water three times, and leaves with any signs of bleaching
were discarded. Strawberry leaf discs were then cut using a 15-mm stainless steal cork borer and
placed in moisture plate until they were placed in the 24-well plate.

Pathogen and Inoculum Preparation
Three Colletotrichum isolates were evaluated for their ability to produce disease lesions
under in vitro conditions.

Colletotrichum fragariae (CF75), C. fragariae (CF63), and C.

gloeosporioides (CG162) isolated from strawberry were evaluated for their ability to produce
anthracnose symptoms on excised strawberry leaf discs.

Each Colletotrichum isolates was

grown on 1/2 strength potato dextrose agar (PDA) in 9-cm Petri dishes and incubated under
(55±5 µmols·m-2·sec-1) Ushio Ultra 8 fluorescent lights (UFL-F17T8/741, Interlectric Corp.,
Warren, PA, USA) at 25º C as previously described (Abril et al., 2008). Conidia were harvest
from 7- to 10-day-old cultures, and the aqueous conidial suspensions were filtered through sterile
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Miracloth (Calbiochem-Novabiochem Corp., La Jolla, CA, USA) to remove hyphae. Conidial
concentrations were determined photometrically from a standard curve based on absorbance at
625 nm (Espinel- Ingrof and Kerkering, 1991; Wedge and Kuhajek, 1998), and then stock
suspensions were adjusted with sterile water to a concentration of 106 conidia / ml.

Surfactant and Inoculum Volume
Three concentrations of Tween 20 were evaluated for their effects on promoting pathogen
infection of the leaf disk. Tween 20 concentrations of 0.3 %, 0.5 %, and 0.7% were prepared in
100 ml sterile distilled water. Conidial suspensions for inoculation were adjusted to a final
concentration of 1.0 ×105 conidia / ml. Two inoculum volumes were also evaluated where the
inoculum volume applied to each leaf disk was either 10 or 20 µl of either of the three fungal
spore suspensions. After inoculation the 24-well were plates were sealed with paper-based tape
and placed in the incubator under (55±5 µmols·m-2·sec-1) Ushio Ultra 8 fluorescent lights (UFLF17T8/741, Interlectric Corp., Warren, PA) with a 12 h photoperiod in a growth chamber at 25º
C for 6 days.

Fungicidal and phytotoxicity
Experimental compounds were evaluated in a dose-response format. Azoxystrobin that
have protective and some curative activity were used as standards for comparison. A 20%
ethanol:water solvent control is used in each study to solubilize lipophilic extracts. Angelica
sinensis roots were purchased as a plant material from Jincheng Lingyi Drugstore, Weinan City,
Shaanxi Province, China. Origanim onites essential oil was purchased from ALTES company,
Turkey. Stock solutions containing 625, 1250, and 2500 ppm were prepared for azoxystrobin,
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Origanum onites essential oil, Angelica sinensis essential oil and 20% ethanol solvent control in
50 ml capped test tubes.
Strawberry leaf disks prepared as previously described were dipped in antifungal test
solutions for 3-5 seconds, excess solution was allowed to drain onto the edge of the test tube and
then placed into the appropriate row and column of the 24-well plates. Plates were incubated
over night at room temperature and inoculated the next morning with either 20 ul of conidial
solution obtained from either C. fragariae (CF75), C. fragariae (CF63), or C. gloeosporioides
(CG162). Percent healthy tissue, percent leaf necrosis, and percent phytotoxicity were
determined at 5 days after inoculation by a Lemnatec Lemna HTS and SAW Scanalyzer
analyzing software (LemnaTec GmbH, Wurselen, Germany). The instrument was set up to
photograph (Sony DFW-SX900 camera) a 24-well plate containing the leaf disks using both top
lighting and bottom lighting (8 W fluorescent tubes) and optimized for disk clarity and color.
The software configurations were set to measure the area of each disk separately and classify the
colors detected within each leaf and color classification was set to differentiate healthy tissue,
bleached tissue, and necrotic lesions on the leaf surface.

Experimental Design
SAS (Statistical Analysis System, Cary, N.C.) was used to conduct analysis of variance
and mean separation tests on all three experiments. A completely randomized design was used
for all experiments.

All factors were considered to be fixed effects, except for surfactant

concentration in the surfactant experiment. Fisher's protected LSD was used to separate means
(Steel and Torrie, 1980).
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Results and discussion

24-well Leaf Disk Assay/ Salt solutions
Leaf color index obtained from visual evaluation of the leaf disks at 7 days indicated that ½
strength Hoaglands No. 2 basal salt media provided excised leaf discs with the best physiological
support with a color index of 2.67. Murashige and Skoog basal salts demonstrated the lowest
color index of 1.83. While MES salts and water had a color index of 2.42 and 2.83 respectively.
However, MES and water did not gel sufficiently to provide adequate physical support to keep
leaf disks (Figure 1) afloat for subsequent inoculation with the conidial solutions (Table 1).
Typical working concentrations for Phytagel™ are 1.5-2.5 g/L in plant tissue culture media
and up to 10 g/L in microbiological media. Phytagel™ requires the presence of cations
(especially divalent) for gelling to occur. Concentrations of calcium and magnesium contained in
most plant tissue culture media are typically sufficient for gelation. Low-salt media formulations,
especially those used in microbiological applications may require supplementation with
additional calcium or magnesium salts (e.g., CaCl2 or MgSO4) or higher concentrations of
Phytagel. Therefore we chose ½ strength Hoaglands No. 2 basal salt media containing 1%
Phytogel as the best medium to conduct all subsequent 24-well leaf disk studies.

Pathogen type, surfactant, and inoculum volume
Colletotrichum fragariae (CF75), C. fragariae (CF63), and C. gloeosporioides (CG162)
were each evaluated for their ability to produce disease lesions under in vitro conditions at three
levels of Tween 20 (0.3 %, 0.5 %, and 0.7%). Mean necrosis indicated that Colletotrichum
fragariae (CF75) and C. gloeosporioides (CG162) produced the highest number of lesions under
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in vitro conditions and C. fragariae (CF63) produced the lowest number of lesions (Table 2).
The best treatment combination was C. fragariae (CF75) where inoculum amended with 0.5%
and 0.7% Tween 20 produced 16.72 and 15.53 % necrosis of the leaf disks respectively. C.
gloeosporioides (CG162) showed no significant differences in leaf lesions between the three
Tween 20 concentrations. Lesion development (necrosis) indicated that there was no difference
between 10 or 20 µl inoculum volumes for either of the three Colletotrichum spore suspensions
when applied to the leaf disk surface.

Fungicidal and phytotoxicity
Phytotoxicity evaluations were made visually at 12 hrs after treatment of the fungicidal
solution or solvent control and prior to inoculation (Figure 1).

Origanum onites essential oil

above 1250 ppm demonstrated a 4+ phytotoxicity ranking and A. sinensis essential oil
demonstrated 1+ phytoxicity ranking at 2500 ppm. Percent healthy tissue, % bleached tissue,
and % necrosis of the leaf disk are presented in Table 3. The commercial fungicide azoxystrobin
had the greatest level of disease control efficacy at 99% healthy tissue at 625 ppm and the lowest
level of phytotoxicity (0.45%) at 2500ppm.

Both O. onites and A. sinensis essential oils

demonstrated phytotoxicity in a dose-dependent manner that was shown visually in Figure 1 and
Figure 2, Plate 1a. Color analysis presented in Figure 2, Plate 1b show healthy area in green,
diseased area in black and phytotoxicity in gray. Origanum onites essential oil was more
phytotoxic to strawberry leaves than was A. sinensis essential oil. Angelica sinensis essential oil
appeared to be a more effective antifungal solution and was effective against all three
Colletotrichum species and had a lower % necrosis that did O. onites essential oil.
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Conclusions
Discovery and evaluation of natural product fungicides is largely dependent upon the
availability of miniaturized antifungal bioassays.

Essentials for natural product bioassays

include sensitivity to microgram quantities, selectivity to determine optimum target pathogens,
and adaptability to complex mixtures. These assays should be relevant to potential pathogen
target sites in the natural infection process of the host and applicable to the agrochemical
industry. Bioassays need to take advantage of high-throughput technology to evaluate doseresponse relationships, commercial fungicides standards, modes of action, and structure activity
studies [18, 22].
The 24-well leaf disk bioassay has numerous advantages over conventional pot or field
studies. The most important aspect of an in vitro assay is that testing is conducted under
controlled conditions and miniaturized so that micro amounts of experimental compounds can be
studied. The addition of digital photography and color imaging and analysis software make this
assay a very powerful technique to evaluate lipophilic and other lead compounds directly on the
leaf surface. Images can be stored electronically and analyzed at one’s convenience rather that
trying to conduct visual assessments in the field in the blazing sun or on a cold-wet windy day.
Moreover, the opportunity to go back and adjust the color images and the analysis parameters to
fine tune the data analysis that was frozen in time can not be replicated in the greenhouse or in
the field. Identification of new potential lead compounds can be repeated quickly in time and
real on-the-leaf-surface activity can be evaluated in high throughput formats and published in a
reasonable time. There will still be a place for the studies evaluating multiple geographical
locations and 3-year repeated studies but cost and efficiency of discovery research will continue
to drive the need for the development of new techniques such as the 24-well leaf disk assay.
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Table 1.

Half strength Hoagland’s No. 2, 2-N-morpholino ethanesulfonic acid (MES),

Murashige and Skoog basal salt mixture (MS, and water (control) were evaluated for their ability
to sustain excised leaf discs for 7-10 days. Mean leaf color index on a scale from 1-3 (1 = light
green, 2 = medium green, 3 = dark green) was used to describe leaf chlorophyll content.

Salt Solution

Leaf Color Value (1-3)

Standard Error

H2 O

2.83 a

0.11

½ Hoagland’s

2.67 a

0.22

M&S
MES

1.83 ab

0.30

2.42 b

0.19

Means followed by the same letter are not significant at p<0.05.
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Table 2.

Percent mean necrosis was used evaluate the ability of Colletotrichum fragariae

(CF75), C. fragariae (CF63), and C. gloeosporioides (CG162) and three concentrations of
Tween 20 (0.3 %, 0.5 %, and 0.7%) in the inoculum solution to produce disease lesions on 15
mm leaf disks.

Fungal isolate & % Tween 20

% Mean Necrosis

Standard Error

Cf63

0.3

7.34 cde

2.53

Cf63

0.5

4.84 efg

1.12

Cf63

0.7

5.78 def

2.05

Cf75

0.3

10.78 bcd

2.13

Cf75

0.5

16.72 a

0.93

Cf75

0.7

15.53 ab

8.52

Cg162

0.3

12.47 abc

3.27

Cg162

0.5

11.58 abc

2.02

Cg162

0.7

12.00 abc

3.20

H2 O

0.3

0.56 fg

0.00

H2 O

0.5

0.14 g

0.00

H2 O

0.7

0.00 g

0.00

Means followed by the same letter are not significant at p<0.05.
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Figure 1. 15-mm excised leaf disks from anthracnose susceptible strawberry cultivar ‘Chandler’
demonstrate easy to visualize 4+ phytotoxicity of Organium onites essential oil above 1250 ppm.
Angelica sinensis essential oil demonstrated 1+ phytoxicity at 2500 ppm. Row A contained
azoxystrobin, row B contained Organium onites essential oil, row C contained Angelica sinensis
essential oil at three concentrations. Row D contained 20% ethanol/water solvent control.
Column 1 and 2 contain 625 ppm, column 3 and 4 contain 1250 ppm, and row 5 and 6 contain
2500 ppm of the respective test compounds or extracts.
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Figure 2. Plate 1a is a photographic image of 15-mm excised leaf disks from anthracnose
susceptible strawberry cultivar ‘Chandler’ following 3-5 second dip in fungicide test solutions in
a dose-response format and inoculated 12 hrs later with Colletotrichum fragariae isolate #75.
Plate 1b is an image analysis of Plate 1a using the LemnaTec and SAW Scanalyzer analyzing
software showing healthy tissue in green, diseased (necrotic) lesions in black, and bleached
tissues
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gray.

Table 3. Percent healthy tissue, % leaf necrosis, and % phytotoxicity as determined at 5 days
after inoculation by a Lemnatec Lemna HTS and SAW Scanalyzer analyzing software.
Colletotrichum fragariae (CF75), C. fragariae (CF63), and C. gloeosporioides (CG162) were
the test isolates used in these experiments.

Azoxystrobin

Origanium onites

Angelica sinensis

625

1250

2500

625

1250

2500

625

1250

2500

ppm

ppm

ppm

ppm

ppm

ppm

ppm

ppm

ppm

Control

% Healthy Tissue
Cf75

99.29 98.93 99.16 65.03 9.79

16.43 92.59 79.65 36.73 86.18

Cf63

99.55 99.51 99.64 96.17 7.32

20.94 96.02 72.20 16.18 92.22

Cg162

99.65 99.21 99.80 98.66 33.72 17.42 98.53 97.33 27.64 94.27

% Leaf Necrosis
Cf75

0.40

0.55

0.39

25.81 29.78 1.02

6.49

8.78

9.59

13.01

Cf63

0.13

0.23

0.03

3.39

17.17 0.33

2.89

7.58

0.09

6.85

Cg162

0.04

0.40

0.09

1.13

15.97 7.19

1.05

1.42

0.91

4.85

% Phytotoxicity
Cf75

0.31

0.52

0.45

9.16

60.44 82.55 0.92

11.57 53.67 0.80

Cf63

0.31

0.26

0.33

0.44

75.51 78.72 1.09

20.21 83.73 0.93

Cg162

0.31

0.39

0.11

0.21

50.31 75.39 0.42

1.25
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